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 1 
ABSTRACT 
Assembly of cytochrome c oxidase (COX), the terminal enzyme of the 
mitochondrial respiratory chain, requires a concerted activity of a number of 
chaperones and factors for the correct insertion of subunits, accessory 
proteins, cofactors and prosthetic groups. Most of the fundamental biological 
knowledge concerning mitochondrial copper homeostasis and insertion of 
copper into COX derives from investigations in the yeast Saccharomyces 
cerevisiae. In this organism, Cox17 was the first identified factor involved in 
this pathway. It is a low molecular weight protein containing highly conserved 
twin Cx9C motifs and is localized in the cytoplasm as well as in the 
mitochondrial intermembrane space. It was shown that copper-binding is 
essential for its function.  
So far, the role of Cox17 in the mammalian mitochondrial copper metabolism 
has not been well elucidated. Homozygous disruption of the mouse COX17 
gene leads to COX deficiency followed by embryonic death, which implies an 
indispensable role for Cox17 in cell survival.  
In this thesis, the role of COX17 in the biogenesis of the respiratory chain in 
HeLa cells was explored by use of siRNA. The knockdown of COX17 results in 
a reduced steady-state concentration of the copper-bearing subunits of COX 
and affects growth of HeLa cells accompagnied by an accumulation of ROS 
and apoptotic cells. Furthermore, in accordance with its predicted function as 
a copper chaperone and its role in formation of the binuclear copper center of 
COX, COX17 siRNA knockdown affects COX-activity and -assembly. It is now 
well accepted that the multienzyme complexes of the respiratory chain are 
organized in vivo as supramolecular functional structures, so called 
supercomplexes. While the abundance of COX dimers seems to be unaffected, 
blue native gel electrophoresis reveals the disappearance of COX-containing 
supercomplexes as an early response. Accumulation of a novel ~150 kDa 
complex containing Cox1, but not Cox2 could be observed. This observation 
may indicate that the absence of Cox17 interferes with copper delivery to 
Cox2, but not to Cox1. Data presented here suggest that supercomplex 
formation is not simply due to assembly of completely assembled complexes. 
Instead an interdependent assembly scenario for the formation of 
supercomplexes is proposed that requires the coordinated synthesis and 
association of individual complexes. 
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1 INDRODUCTION 
1.1 MITOCHONDRIA AND THE RESPRIRATORY CHAIN  
Mitochondria are complex subcellular organelles which perform a wide range 
of necessary functions, including ATP production, citric acid cycle, fatty acid 
oxidation, calcium homeostasis, and the production of heme and iron-sulfur 
clusters (Rizzuto et al., 1998; Scheffler, 2001; McBride et al., 2006). Finally, 
they play an important role in the regulation of apoptosis (Green and Reed, 
1998). 
Structurally, mitochondria contain two membranes that separate four distinct 
compartments: the outer membrane (OMM), intermembrane space (IMS), 
inner membrane (IMM), and the matrix. The two membranes are themselves 
very different in structure and in function. The OMM contains numerous 
integral porin proteins, resulting in a membrane that is permable to water, 
ions, and small proteins (< 5000 Da) (Mannella, 1992; Vander Heiden et al., 
2000). The IMM is impermeable, enabling the maintenance of the 
transmembrane potential (ΔΨ). It is highly folded into cristae, which house 
the megadalton complexes of oxidative phosphorylation (OXPHOS) (Gilkerson 
et al., 2003). 
As the site of OXPHOS, mitochondria provide a highly efficient route to 
generate ATP from energy-rich molecules. Respiration consists of the 
sequential transfer of electrons extracted from nutrient compounds through 
the chain of oxidoreductase reactions, leading to reduction of molecular 
oxygen to water. Briefly, electrons are transported in the respiratory chain 
(RC) from NADH or succinate to complex I (NADH ubiquinone oxidoreductase) 
or complex II (succinate ubiquinone oxidoreductase), respectively, and further 
via complex III (ubiquinol cytochrome c oxidoreductase) and complex IV 
(cytochrome c oxidase, COX) to the terminal acceptor molecular oxygen 
(Hatefi, 1985). In the process, protons (H+) are pumped from the matrix 
across the IMM into the IMS through respiratory complexes I, III, and IV 
(Babcock and Wikstrom, 1992). The resulting electrochemical proton gradient 
(ΔΨ) finally leads to the production of ATP by phosphorylation of ADP via 
complex V (F1F0-ATP synthase) (Figure 1.1).  
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ATP is generated by the coordinated activity of five multimeric enzyme complexes. 
Complex I accepts electrons from NADH, and passes them to coenzyme Q (UQ), which 
also receives electrons from complex II. UQ transfers electrons to complex III, which 
passes them to cytochrome c (Cyt c). Cytochrome c delivers electrons to complex IV, 
which uses the electrons and hydrogen ions to reduce molecular oxygen to water. As 
electrons are transported from one complex to another, protons (H+) are pumped from 
the mt matrix into the mt IMS, creating an electrochemical proton gradient across the 
IMM, called ΔΨ. This electrochemical proton gradient allows ATP synthase to use the 
flow of H+ through the enzyme back into the matrix to generate ATP from ADP and 
inorganic phosphate (http://tyrosine.umdnj.edu/w wiki/index.php). 
 
Two different models were proposed to describe the arrangement of RC 
complexes in the IMM. Spectrophotometric pioneering studies of Chance and 
Williams (1955) depicting the RC as a solid state assembly, in which the 
substrates are directly channelled between the complexes. This model was 
substantially confirmed (Capaldi, 1982; Gupte et al., 1984), leading to the 
postulation of the random collision model, according to which the complexes 
diffuse individually in the IMM (Hackenbrock et al., 1986). Much more 
recently, Schägger and Pfeiffer (2000) produced new evidence in favor of a 
solid state organization of the entire OXPHOS system. They found specific 
aggregation of the RC complexes to so called supercomplexes (SCs) and 
introduced the model of the ‘respirasome’. 
Recent data by Acin-Pérez and coworkers (2008) convincingly show that in 
mammalian cells RC complexes assemble into functional SCs (Figure 1.2). In 
addition to a complex I monomer (I1) and a comple III dimer (III2) SCs 
contain either no or a variable number of complex IV (IV0-4), whereby I1III2IV1 
of approximately 1,7 MDa seems to represent the major physiological module 
of the mammalian RC (Schägger and Pfeiffer, 2000, 2001; Schäfer et al., 
Figure 1.1. Oxidative phosphorylation. 
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2006). The data as well suggest that complexes II and V are also engaged in 
SC formation (Acin-Pérez et al., 2008). Several roles have been proposed for 
SCs, including substrate channelling, catalytic enhancement (Schägger and 
Pfeiffer, 2000), and stabilization of protein complexes (Acin-Pérez et al., 
2004). The importance of complex IV for the assembly and stability of 
complexes I and III in their supramolecular organization has been 
demonstrated (Schägger et al., 2004; Schäfer et al., 2006; Suthammarak et 
al., 2009). Pulse-chase experiments revealed that SC formation is a specific 
and ordered process of individual complexes and not caused by preparative or 
electrophoretic artefacts (Acin-Pérez et al., 2008).  
 
 
  
3D map (obtained from electron microscopy) of complex I (yellow), X-ray structure of 
the complex III dimer (red) and X-ray structure of complex IV (green). The left 
column shows a surface representation in blue of the supercomplex I1III2IV1 3D map. 
The middle column displays the 3D map with a semitransparent surface and the fitted 
structures of the individual complexes. The right column shows only the three 
individual complexes as they would assemble to form the supercomplex. The location 
of the membrane is depicted in purple (taken in part from Schäfer et al. (2007)). 
 
1.2 THE HUMAN MITOCHONDRIAL GENOME  
The 16,569 base pairs long, double-stranded, circular, self-replicating 
mitochondrial DNA (mtDNA) molecule (Anderson et al., 1981) encodes 13 of 
the approximately 90 subunits that form the RC, the remaining ones being 
encoded by the nuclear genome (nDNA). These latter proteins are synthesized 
in the cytoplasm and imported into mitochondria where they are assembled, 
together with the mtDNA encoded subunits, to form the RC complexes of the 
IMM (Lang et al., 1999). Moreover, mtDNA encodes two ribosomal RNAs 
(rRNAs) and 22 transfer RNAs (tRNAs) for the internal mt translation 
machinery, which uses its own genetic code (Barrell et al., 1979).  
Figure 1.2. Model of mammalian I1III2IV1 supercomplex.
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In contrast to the nDNA, mtDNA is not associated with histones but organized 
in nucleoids, nucleoprotein complexes associated with the IMM (Iborra et al., 
2004; Legros et al., 2004). Each human nucleoid is supposed to contain two 
to eight mtDNA molecules and distributed throughout the entire mt 
compartment (Legros et al., 2004). The mt genome shows a compact gene 
organization, with only 1.1 kilobase pairs of non-coding DNA sequence.  
 
The mechanism of mtDNA replication is not fully understood, but for almost 
30 years mtDNA replication was assumed to occur through a strand-
displacement mechanism (SDM) (Robberson et al., 1972). This model 
proposes an asynchronous strand replication in which both strands 
(heavy/leading (H) and light/lagging (L)) of the circular genome are replicated 
semi-independently. The replication of mtDNA starts in the major non-coding 
(regulatory) region (D-loop) as it contains the H-strand replication origin, 
designated as OH, displacing the L-strand from the H-strand. The L-strand is 
single stranded until synthesis of the nascent H-strand exposes the L-strand 
replication origin, OL. At this point, replication of the L-strand starts in the 
opposite direction until both strands have been completely replicated. The 
alternative RITOLS (RNA incorporation throughout the lagging strand) model 
proposes both, a bidirectional coupled H-strand and L-strand synthesis mode 
as well as an unidirectional mode in which the L-strand is initially laid-down as 
RNA (Holt et al., 2000). Very recently, Pohjoismaki and co-workers (2010) 
convincingly confirmed the RITOLS model, in which the replication initiates in 
the non-coding region close to or at OH, displacing the L-strand from the H-
strand. The RITOLS model is similar to the asynchronous mode of replication, 
but RNA intermediates are produced on the L-strand preceding conversion to 
DNA (Krishnan et al., 2008). 
 
Approximately 1,500 different mt proteins exist (Distler et al., 2008), 
whereby the mammalian mt proteome exhibits considerable tissue 
heterogeneity (Chan, 2006; Reifschneider et al., 2006; Johnson et al., 2007). 
Mitochondria are active structures and their morphology and intracellular 
dynamics can be tightly controlled by the processes of continuous fission-
fusion events, inner membrane/cristae formation and mt remodeling (Chan, 
2006). Consequently, in most mammalian cells mitochondria exist as 
branched chain reticulum networks with a diverse distribution within the cell. 
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Most frequently, mitochondria localize to sites where ATP demand is highest 
(Li et al., 2004), and it could be shown that tissues with high demand for 
aerobic respiration, such as skeletal muscle and heart, have the most 
prominent reticulum network (Kirkwood et al., 1986; Bach et al., 2003). In 
addition, movement of mitochondria is mediated by the interaction with the 
cytoskeleton and their transport is modulated in response to physiological 
signals (Hollenbeck and Saxton, 2005). 
 
1.3 HOMOPLASMY AND HETEROPLASMY  
The mt genome is exclusively maternal inherited and present at high copy 
number within a typical human cell (~1,000–4,000 copies / cell) (Giles et al., 
1980; Lightowlers et al., 1997; Legros et al., 2004). The multiple copies of 
mtDNA per cells are homoplasmic in normal cells, however, recent studies 
revealed an apparently low level of heteroplasmy* in the mtDNA (He et al., 
2010). The frequency of heteroplasmic variants differs between various 
tissues of the same individual, indicating that an individual does not have a 
single mtDNA genotype. These heteroplasmic variants may be maternally 
inherited or the result of somatic mutations (Polyak et al., 1998; Wai et al., 
2008; He et al., 2010). 
The level of heteroplasmy is an important factor in determining the amount of 
mt dysfunction, because clinical phenotypes are often assumed to be 
associated with a threshold level of mutation (Sciacco et al., 1994).  
 
1.4 MITOCHONDRIAL DISORDERS 
OXPHOS is under the genetic control of the nDNA and the maternally inherited 
mtDNA. Mt diseases might occur by defects in both genomes, whereby tissues 
with high energy demand such as the brain, muscle and heart, are affected 
most frequently.  
                                                 
*Homoplasmy is the genetic state of mitochondria, in which all of the mtDNA copies are identical 
within a cell or an individual, whereas heteroplasmy describes the coexistence of two or more 
genotypes.  
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1.4.1 MUTATIONS IN MITOCHONDRIAL DNA  
Human mtDNA mutations were discovered for the first time in 1988 (Holt et 
al., 1988 and Wallace 1988), and today hundreds of points mutations, 
deletions, or rearrangements in mtDNA associated with diseases are known 
(Chan, 2006).  
Maternal inherited mutations in mtDNA may cause mt diseases including 
muscle weakness, diabetes, stroke, or heart failure (Giles et al., 1980; Ankel-
Simons and Cummins, 1996; Chan, 2006). In almost all mt diseases caused 
by mutant mtDNA, the patients cells are heteroplasmic with normal and 
mutant mtDNA coexisting (Wallace, 1999). A minimum critical number of 
mutated mtDNA molecules has to be present before clinical symptoms appear 
and it seems likely that the pathogenic threshold is lower in tissues that are 
dependent on oxidative metabolism (White et al., 2005). However, the 
proportion of mutant mtDNA in most cases determines the severity of disease 
(Macmillan et al., 1993; Elliott et al., 2008).  
Classical mt diseases, like myoclonic epilepsy associated with ragged-red 
fibres (MERRF) (Shoffner et al., 1990) or mt encephalomyopathy with lactic 
acidosis and stroke-like episodes (MELAS) (Enter et al., 1991) are caused by 
point mutations in tRNAs. The same mutation can thereby trigger different 
clinical outcome, for example the base substitution A3243G (Goto et al., 
1990), the most common mutation of MELAS, can sometimes cause less 
severe disorders like maternally inherited diabetes with deafness (MIDD) or it 
may lead to neurogenic muscle weakness, ataxia, and retinitis pigmentosa 
(NARP)) (Kirches et al., 2001). It is hypothesized that the heterogeneous 
tissue distribution might cause this variety of distinct diseases. In contrast, 
different mutations can result in similar phenotypes, which e.g. are associated 
with progressive neurodegenerative disorder of infancy and early childhood 
(Leigh syndrome (Leigh, 1951)) (Naess et al., 2009).  
Large deletions or duplications in the range of several kilobase pairs are 
observed in the three main clinical phenotypes: Chronic Progressive External 
Ophthalmoplegia (CPEO), in Pearson's Syndrome and in Kearns-Sayre 
Syndrome (KSS) (Wallace, 1992). The majority of these large-scale 
rearrangements of mtDNA are sporadic and therefore supposed to be the 
result of single mutational event occurring in the early embryonic 
development (Schon et al., 1989; Chen et al., 1995).  
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1.4.2 MUTATIONS IN NUCLEAR DNA 
Nuclear encoded gene products account for many mt diseases, including 
disorders due to (i) nuclear gene defects encoding structural components or 
assembly factors of the OXPHOS system, (ii) gene defects altering the 
abundance and stability of the mtDNA and (iii) gene defects encoding non-
OXPHOS mt proteins (Zeviani and Di Donato, 2004).  
Disorders due to nuclear gene defects encoding structural components or 
assembly factors of the OXPHOS system are the main group of diseases 
associated with nDNA abnormalities. Several disease-associated mutations in 
nDNA encoded structural subunits of complex I, II and III have been 
identified (Bourgeron et al., 1995; Loeffen et al., 1998; Budde et al., 2000; 
Triepels et al., 2001; Haut et al., 2003). In most cases, the affected 
individuals show clinical characteristics of Leigh syndrome, occasionally 
complicated by cardiomyopathy, or multisystem involvement (Morris et al., 
1996; Parfait et al., 2000).  
Defects of genes involved in the assembly of respiratory complexes affect, so 
far, the assembly of complex III, IV and V (Tiranti et al., 1998; de Lonlay et 
al., 2001; De Meirleir et al., 2004; Leary et al., 2007). Mutations in assembly 
factors of complex IV, including SURF1, SCO1, SCO2 and COX10, are thereby 
the most common observation (Papadopoulou et al., 1999; Valnot et al., 
2000a; Valnot et al., 2000b; Agostino et al., 2003). Particularly, mutations in 
SURF1, which encodes a 30 kDa hydrophobic protein located in the IMM, are 
relatively frequent and account for the majority of the Leigh syndrome cases 
due to COX deficiency (Tiranti et al., 1999).  
The second group comprised nDNA mutations in factors altering the 
abundance and stability of the mtDNA. Mutations in POLG1 and POLG2, 
encoding mt polymerase gamma 1 and 2, respectively, are of particular 
interest (Van Goethem et al., 2001; Hudson and Chinnery, 2006). They 
represent the most common causes of autosomal dominant progressive 
external ophthalmoplegia (adPEO) (Spinazzola and Zeviani, 2005), a mt 
disease characterized by accumulation of multiple large deletions of mtDNA in 
patients tissues (Suomalainen et al., 1997).  
Several neurodegenerative disorders are associated with an impairment of mt 
biogenesis and OXPHOS. These are diseases caused by mutations in nuclear 
genes encoding non-OXPHOS mt proteins, such as frataxin in Friedreich 
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ataxia, a mt protein which is likely to play an important role in iron handling 
and iron-sulfur protein maintenance (Campuzano et al., 1997; Martelli et al., 
2007) and Ddp1 (deafness dystonia protein 1), a component of the import 
machinery, which is responsible for X-linked deafness-dystonia syndrome 
(Koehler et al., 1999).  
 
1.5 CYTOCHROME C OXIDASE 
The cytochrome c oxidase (COX) is the terminal enzyme of the eukaryotic RC. 
This membrane embedded complex acts as a dimer (Henderson et al., 1977; 
Frey and Murray, 1994) and faces both, the mt IMS and the mt matrix, 
whereas it emerges slightly more to the mt IMS side (Carr and Winge, 2003). 
According to the structure of the bovine enzyme, mammalian COX is 
composed of 13 structural subunits, with the three mtDNA encoded subunits 
Cox1, Cox2 and Cox3 forming the catalytic core of the enzyme (Tsukihara et 
al., 1996; Yoshikawa et al., 1998). The two heme a moieties (a and a3) and 
the two copper centers (CuA and CuB) within subunits Cox1 and Cox2 are 
responsible for the electron transfer and are essential for catalytic 
competence (Capaldi, 1990). The remaining ten subunits (Cox4, Cox5a, 
Cox5b, Cox6a, Cox6b, Cox7a, Cox7b, Cox7c and Cox8), which are thought to 
play a role in stabilizing the enzyme and modulating its activity (Arnold and 
Kadenbach, 1997; Kadenbach et al., 2000), are encoded in the nDNA and 
have to be imported and assembled in concert with the mtDNA encoded 
subunits.  
 
Figure 1.3 (a) presents an illustration of mammalian COX, showing exclusively 
subunits that contain cofactors or are engaged in early assembly steps of the 
enzyme. The crystal structure of the dimeric COX from bovine heart is 
depicted in Figure 1.3 (b).  
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(a) Illustration of mammalian COX subunits that contain cofactors or are enganged in 
early assembly steps (according to Khalimonchuk and Rödel (2005) and Fernandez-
Vizarra et al. (2009)). (b) Structure of the bovine COX (taken in part from Carr and 
Winge (2003)). The three mt encoded subunits Cox1, Cox2 and Cox3 are highlighted 
in yellow, blue and green, respectively. 
 
COX catalyzes the reduction of molecular oxygen to water and concomitantly 
the oxidation of reduced cytochrome c. During the catalytic cycle, reduced 
cytochrome c binds to Cox2 and transfers electrons to the CuA site, which is 
located in the COX domain projecting to the IMS. Reduced CuA then transfers 
the electrons through heme a to the heme a3/CuB binuclear reaction center, 
both associated with Cox1, where they are used to reduce molecular oxygen 
to water (Figure 1.4).  
 
A single redox cycle of the COX is accompanied by the transport of two 
protons from the matrix to the mt IMS, thus contributing to the 
transmembrane proton gradient and providing the free energy needed for ATP 
synthesis (Wikstrom, 1977).  
 
Figure 1.3. Molecular organization of COX.
ΔΨ 
(a) (b) 
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The IMM and the metal centers involved in electron transfer reactions are shown. 
Electrons are transported from reduced cytochrome c to the CuA site within the subunit 
Cox2. Reduced CuA transfers the electrons through heme a to the heme a3/CuB 
binuclear center within Cox1, where they are used to reduce molecular oxygen to 
water (according to Khalimonchuk and Rödel (2005)).  
 
For the proper assembly of a functional holoenzyme complex, additional 
nuclear encoded accessory factors are necessary. In Saccharomyces 
cerevisiae (S. cerevisiae), approximately 20 accessory proteins are required 
for COX biogenesis and are involved in specific stages of the assembly process 
(Grivell et al., 1999; Fontanesi et al., 2006). More than a half of these 
proteins have known human homologues (Petruzzella et al., 1998; Barrientos 
et al., 2002). 
 
1.6 CYTOCHROME C OXIDASE ASSEMBLY 
The assembly of the multi-subunit COX complex is a complicated sequential 
process that involves the coordinated action of two genomes. Expression of 
mtDNA encoded subunits, expression of nDNA encoded subunits and import 
into the mitochondria, as well as the addition of prosthetic groups prior to 
COX assembly are tightly regulated processes (Fontanesi et al., 2006). The 
knowledge of the COX assembly process is still limited despite the efforts of a 
large number of laboratories.  
 
Studies in human cells have revealed three distinct COX assembly 
intermediates, so called subcomplexes S1, S2 and S3, that probably represent 
rate-limiting steps in the process (Figure 1.5) (Nijtmans et al., 1998). The 
Figure 1.4. Illustration of the electron flow through the COX.
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first (S1) consist exclusively of Cox1 which is the most hydrophobic and 
biggest (57 kDa) protein of the core subunits (Capaldi, 1990). It spans the 
IMM with twelve transmembrane helices (Carr and Winge, 2003) and appears 
to be the key subunit for both, the assembly and function of COX.  
The subcomplex S2 comprises Cox1, Cox4 and Cox5a. The insertion of 
heme a into Cox1 is required for the formation of S2 subcomplex, as patients 
with mutations in COX10 and COX15, two enzymes involved in the terminal 
steps of the heme a biosynthetic pathway (Barros et al., 2002; Barros and 
Tzagoloff, 2002), fail to accumulate the S2 assembly intermediate (Antonicka 
et al., 2003a; Antonicka et al., 2003b; Williams et al., 2004). The insertion of 
heme a3 and CuB are likely to occur concertedly, prior to incorporation of Cox2 
into the S3 complex (Stiburek et al., 2006). Metallation of Cox2, the smallest 
(26 kDa) and least hydrophobic core subunit possessing two transmembrane 
domains, is likewise necessary for the progression to the S3 stage of COX 
assembly. S2 intermediates accumulate in patients with mutations in SCO1 
and SCO2 (Leary et al., 2004; Williams et al., 2004; Stiburek et al., 2005), 
two metallochaperones responsible for the insertion of copper into the COX 
catalytic center. After insertion of Cox2 a cascade-like, rapid incorporation of 
most of the remaining COX subunits occurs to produce S3. Finally, after 
addition of Cox6a, Cox7a, or Cox7b the assembly of the monomeric 
holoenzyme (S4) is completed (Nijtmans et al., 1998).  
Further maturation to form a COX dimer and additional assembly into 
supercomplexes are necessary to maximize its efficiency and to facilitate the 
aerobic production of ATP (Poyton and McEwen, 1996; Krause et al., 2004). 
 
 
 
Three assembly intermediates in the biosynthetic pathway leading to the formation of 
holo-COX (S4). According to Nijtmans et al. (1998), Stiburek et al. (2006) and 
Fernandez-Vizarra et al. (2009).  
Figure 1.5. Model of the assembly pathway of human COX.
                                                                                                       
                                                                                     INTRODUCTION 
 
 13 
The insertion of cofactors, among them copper for the two redox active metal 
centers CuA and CuB, is responsible for the catalytic activity of the enzyme 
and essential for COX assembly.  
 
1.7 COPPER AND ITS TRAFFICKING IN THE CELL 
Copper is an essential nutrient required for the activity of a number of 
enzymes with diverse biological roles. It is required as a catalytical cofactor 
for a number of biological processes including respiration, iron transport, 
oxidative stress protection, cell growth, and development (Harris, 2000; Puig 
and Thiele, 2002). Copper has the ability to cycle between two redox states, 
oxidized Cu2+ and reduced Cu1+ and due to these redox properties, stringent 
control systems for copper homeostasis are necessary. Metallochaperones 
facilitate the transport of copper ions to specific sites and prevent the 
inappropriate interaction of copper ions with other molecules (Cobine et al., 
2004). A number of copper binding proteins for the delivery of copper into the 
various cellular compartments were initial identified mainly from studies in S. 
cerevisiae (O'Halloran and Culotta, 2000). Nevertheless, the pathways of 
copper metabolism in the cell are evolutionarily conserved (Bartnikas and 
Gitlin, 2001). 
The proposed trafficking routes within mammalian cells are shown in 
Figure 1.6 (Bartnikas and Gitlin, 2001). Copper is taken up by the two high 
affinity transporters Ctr1 and Ctr3 after reduction to Cu1+ on Fre1/2 (Martins 
et al., 1998; Pena et al., 2000; Lee et al., 2002; De Freitas et al., 2003) and 
then delivered to the different compartments by one of the three copper 
chaperons Atox1 (secretory pathway), Ccs1 (metallation of cytoplasmic 
localized superoxide dismutase (SOD1)) and Cox17 (mt pathway). 
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Three pathways of metallochaperone mediated copper delivery are shown. Copper is 
taken up into the cell via Ctr1 and delivered by Cox17, Ccs1 and Atox1 to their 
respective protein targets COX, SOD1 and Wilson and Menkes copper transporting 
ATPases (Bartnikas and Gitlin, 2001). 
 
The transport of copper to the different compartments requires a transient 
interaction between the metallochaperone and the target enzyme. Studies of 
Atox1 (anti-oxidant 1, previously HaH1 for human Atx homolog 1) (Klomp et 
al., 1997) indicate copper dependent interaction between this protein and the 
two human copper transporting ATPases, Atp7A (Menkes protein) and Atp7B 
(Wilson protein). This interaction facilitates the transfer of copper into the 
secretory pathway and copper export from the cell. Results of Hamza et al. 
(2001) emphasize the role of Atox1 as copper chaperone, as homozygous null 
mice died shortly after birth. Cytosolic copper shuttling is mediated by Ccs1 
(copper chaperone for superoxide dismutase), a 70 kDa homodimer, which is 
important for activation of Cu/Zn-superoxide dismutase (SOD1) (Prohaska et 
al., 2003). Ccs1 interacts physically with SOD1 by two putative metal binding 
sites to secure the enzyme during copper insertion (Casareno et al., 1998; 
Eisses et al., 2000). Deletion of CCS1 in the mice revealed a marked 
reduction in SOD1 activity and produces a phenotype similar to SOD1 (−/−) 
mice, which demonstrate the essential role of Ccs1 in mammalian copper 
homeostasis (Wong et al., 2000). The third compartment that requires copper 
ions for normal function are the mitochondria, especially for metallation of 
Figure 1.6. Pathways of copper trafficking within a mammalian cell. 
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COX and mt localized SOD1. The delivery of copper ions to the mitochondria 
and their further distribution will be discussed in more detail below.  
 
1.8 MITOCHONDRIAL COPPER METABOLISM  
The exact pathways of copper trafficking to the mitochondria are not fully 
understood. However, within mitochondria, copper is required for 
incorporation into the COX subunits Cox1 and Cox2 during the biogenesis of 
COX and for maturing the small mt fraction of SOD1 (Cobine et al., 2006a). 
The metallation of these two enzymes occurs within the mt IMS and depends 
on evolutionarily conserved enzyme-specific copper chaperones.  
 
Copper delivery to COX 
The delivery and insertion of copper into COX is still not well understood 
despite of many available data. A number of mt proteins that are able to bind 
copper have been identified in yeast and depletion of most of them results in 
respiratory deficiency (Horn and Barrientos, 2008). These data imply that the 
successful delivery of metals to the site of COX assembly and their proper 
insertion are important steps in the complex formation.  
It has been established that Cox17 participates in this process in both, yeast 
and mammalian cells. However, the mechanisms of metal transfer by Cox17 
as well as distinct protein partners are still not known (Palumaa et al., 2004). 
Involvement of Cox17 in copper homeostasis was originally proposed due to 
the respiratory deficient phenotype of yeast COX17 null mutants, which could 
be rescued by supplementation of high concentrations of exogenous copper 
(Glerum et al., 1996a). Yeast Cox17, a low molecular weight protein 
containing a highly conserved Cx9C motif is localized in the cytoplasm and in 
the mt IMS. Thus, it was proposed that Cox17 could shuttle copper between 
this two compartments (Glerum et al., 1996a; Beers et al., 1997). It was 
subsequently shown that copper binding is essential to its proper function 
(Heaton et al., 2000) and that the function of Cox17 is critical during early 
mammalian development (Takahashi et al., 2002). There is evidence that 
Cox17 delivers copper ions to two additional copper chaperones, Sco1 
(Glerum et al., 1996b) and Cox11 (Carr et al., 2002). These proteins are 
anchored in the IMM through a transmembrane α-helix and participate in the 
copper insertion into the COX CuA (Cox2) and CuB (Cox1) active sites, 
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respectively, via their mt IMS exposed copper binding sites (Horn and 
Barrientos, 2008).  
 
CuA site metallation 
The CuA site in Cox2 is the entry point of the electrons from cytochrome c 
(Figure 1.4). It contains two copper atoms, which are coordinated by a Cx3C 
motif, two histidines, one methionine and the backbone of a glutamine (Speno 
et al., 1995). Sco1, the metallochaperone for the formation of the CuA center, 
was originally identified as essential for COX assembly in yeast (Krummeck 
and Rödel, 1990) and subsequently together with Sco2 as a multisuppressor 
of COX17 null mutants (Glerum et al., 1996b). Further studies of the yeast 
proteins demonstrated physical interactions between both Sco proteins and 
Cox2 (Lode et al., 2000; Lode et al., 2002). This leds to the conclusion that 
these proteins act downstream of Cox17 in the mt copper metabolism. The 
human homologues of SCO1 and SCO2 (Petruzzella et al., 1998) are essential 
for COX assembly, as mutations in either genes result in severe mt disorders 
(Papadopoulou et al., 1999; Jaksch et al., 2000; Valnot et al., 2000a; Salviati 
et al., 2002b). In contrast to their yeast homologues, human Sco1 and Sco2 
have been shown to perform independent, cooperative functions in the 
process of COX assembly, which are absolutely dependent on their Cx3C 
motifs (Leary et al., 2004; Leary et al., 2009a). Additionally, it was shown 
that Cox17 has a dual function which involves the simultaneous reduction of 
the metal-binding cysteine residues of Sco1 and the metal transfer to Sco1 
(Banci et al., 2008a). The authors postulate that Cox17 is the starting point of 
an electron cascade which eventually leads to the reduction of the cysteine 
residues in the CuA site by Sco1. Indeed, very recently Leary et al. (2009a) 
suggested a model in which human Cox17 delivers copper to Sco2, which in 
turn transfers it directly to the CuA site in COX subunit Cox2 in a reaction that 
is facilitated by Sco1. 
 
CuB site metallation 
Metallation of the CuB center of Cox1 is more complicated, as this site is 
buried within the IMM. It is formed by one copper ion coordinated by three 
histidine ligands in close proximity to the heme a/a3 moieties. Studies in 
Rhodobacter sphaeroides led to the conclusion that Cox11 is important for the 
formation of the CuB site, as a COX11 null mutant lacks CuB but not CuA (Hiser 
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et al., 2000). Additionally, yeast COX11 mutants are characterized by 
impaired COX activity due to the degradation of Cox1 subunits and unstable 
heme a (Tzagoloff et al., 1990). Similar to Sco1, Cox11 is tethered to the IMM 
by a single transmembrane helix (Carr et al., 2005) and it was shown that 
yeast Cox11 binds copper via its mt IMS exposed C-terminal part of the 
protein (Carr et al., 2002). It was suggested that copper insertion might occur 
co-translationally into nascent Cox1 by ribosome-associated Cox11 
(Khalimonchuk and Rödel, 2005). This interaction of Cox11 with the mt 
ribosomes is probably mediated through an additional partner, as the matrix 
domain of Cox11 is non-essential for its function (Carr et al., 2005). As for 
Sco1, the direct transfer of copper from Cox17 to Cox11 was shown (Horng et 
al., 2004) and computer models suggest a direct interaction between Cox11 
and Cox1 (Khalimonchuk et al., 2007). However, so far, physical interaction 
between these proteins could not be detected experimentally.  
 
Cox17, Cox19, Cox23, Pet191 and Cmc1 
Several additional low molecular weight proteins, containing the twin Cx9C 
motif present in Cox17, required for COX assembly have been identified in 
yeast (Horn and Barrientos, 2008; Leary, 2010). These proteins include 
Cox19, Cox23, Pet191 and Cmc1, all of which have human homologues 
(Longen et al., 2009). Yeast cells lacking Cox19 are respiratory deficient, but 
this phenotype is not reversed by the addition of exogenous copper salts 
(Nobrega et al., 2002). Mutants of COX23 also fail to assemble COX, but this 
phenotype can be suppressed by exogenous copper when COX17 is 
overexpressed (Barros et al., 2004). Although Cox23 does not physically 
interact with Cox17, Barros and coworkers (2004) suggest a common 
pathway with Cox17 acting downstream of Cox23. At least two other proteins, 
Pet191 (McEwen et al., 1993) and Cmc1 (Horn et al., 2008) share similarities 
with Cox17. Pet191 and Cmc1 are inner membrane-bound mt IMS proteins 
which are required for full assembly of COX. Particularly, Cmc1 performs 
independent functions in the process of mt copper trafficking and transfer 
(Horn et al., 2008).  
Cox17, Cox19 and Cox23 have been shown to possess a dual localization in 
the cytoplasm and mt IMS (Nobrega et al., 2002; Barros et al., 2004). An 
important remaining question concerns the import of these proteins into the 
mt IMS, as the Cx9C motif present in Cox17, Cox19 and Cox23 are critical for 
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this process. Mesecke et al. (2005) proposed a model for the mt import of 
proteins with conserved cysteine motifs. They reported that mt IMS proteins 
traverse the TOM (translocase outer membrane) complex of the OMM in a 
reduced and unfolded conformation. In the mt IMS the proteins are covalently 
trapped by preoxidized Mia40 via disulfide bridges and finally released after 
further isomerization. Reduced Mia40 is reoxidized by the sulfhydryl oxidase 
Erv1, promoting further cycles of protein import into the mt IMS (Bien et al., 
2010).  
Investigations of the redox properties of the disulfides of human Cox17, 
strongly support the existance of a mechanism of cysteine reduction in the 
mt IMS after oxidative folding (Palumaa et al., 2004; Voronova et al., 2007b; 
Banci et al., 2008b). According to the current hypothesis fully reduced Cox17 
(Cox170S-S) is present in the cytoplasm and enters the mt IMS through the 
OMM pores, where it is then oxidized by Mia40 to its biologically active form, 
Cox172S-S. Cox172S-S is able to bind a single copper ion and is now prepared to 
enter the pathway of copper delivery to COX. This mechanism implies that the 
copper metallation steps may occur within the mt IMS. The result that yeast 
Cox17 tethered to the IMM does not affect COX assembly (Maxfield et al., 
2004) further supports the idea that copper loading occurs after import in the 
mt IMS. In addition, deletion of yeast COX17 does not significantly perturb mt 
copper levels (Carr and Winge, 2003; Cobine et al., 2004).  
In the light of the finding that a copper-pool bound to a yet unknown soluble, 
low molecular weight ligand (CuL) exists in the mt matrix (Cobine et al., 
2004; Pierrel et al., 2007), copper metallation reactions can occur within the 
mitochondria through copper transport from the matrix to the mt IMS. So far 
it is not clear how copper ions enter the matrix and can be eventually later 
recruited to the mt IMS. It seems that Cmc1 or other, yet unidentified 
metallochaperones contribute to these processes (Horn et al., 2008; Horn and 
Barrientos, 2008). Copper is then transferred to Cox17 and subsequently to 
the COX copper site-specific Sco1/Sco2 and Cox11 (Arnesano et al., 2005; 
Leary, 2010). 
 
SOD1 and the matrix copper pool  
Cytosolic SOD1 is an ubiquitous small cytosolic metalloenzyme that catalyzes 
the conversion of superoxide anion to hydrogen peroxide (H2O2), for 
protection of the cell against oxygen free radicals (Fridovich, 1995). A small 
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fraction of SOD1 and of its specific metallochaperone Ccs1 is located in the 
mt IMS (Okado-Matsumoto and Fridovich, 2001; Inarrea, 2002; Kira et al., 
2002). The exact role of mt IMS SOD1 in mt function is not known, however, 
it is thought that the enzyme has a functional relationship with the occurrence 
of superoxide in this compartment (Inarrea et al., 2007). The bioactive copper 
pool within the mt matrix is supposed to metallate both, COX and mt SOD1 
(Cobine et al., 2004; Cobine et al., 2006a). 85 % and ~70 % of the total mt 
copper is associated with the matrix copper complex in yeast and mouse liver, 
respectively (Cobine et al., 2006a). At present, it is not clear how copper is 
transported across the IMM. However, it is suggested that its translocation is 
achieved by either a single, bi-directional transporter or two, uni-directional 
transporters (Leary et al., 2009b; Leary, 2010). 
 
1.9 COX17 
Yeast Cox17 is ‘as mentioned above’ a key mt copper chaperone responsible 
for supplying copper ions to COX. The human Cox17 orthologue shares 48 % 
sequence identity with yeast counterpart (Amaravadi et al., 1997). The 
human COX17 is ubiquitously expressed, is composed of three exons and two 
introns and spans approximately 8 kb of genomic DNA (Punter et al., 2000). 
It is a low molecular weight (~7 kDa) hydrophilic protein (UniProtKB/Swiss-
Prot Q14061) which binds copper ions through a highly conserved metal 
binding motif (KPCCXC) (Amaravadi et al., 1997). Cox17 also contains a twin 
Cx9C structural motif.  
In principle Cox17 can exist in three different oxidation states: (i) in the fully 
reduced state where no disulfide bonds are present (Cox170S-S), (ii) as a 
partially oxidized form with two disulfide bonds (Cox172S-S) or (iii) as fully 
oxidized protein with three disulfide bonds (Cox173S-S), which differ 
substantially in their structural features and metal binding properties 
(Voronova et al., 2007a). Fully reduced Cox17 is designed for specific binding 
of four copper ions (Cu4Cox170S-S), partially oxidized Cox17 can bind a single 
copper ion (Cu1Cox172S-S) and fully oxidized Cox17 is not able to bind copper. 
Metal transfer experiments with human Cu1Cox172S–S and Cu4Cox170S-S and 
human Sco1 demonstrated that Cu1Cox172S–S and not Cu4Cox170S-S forms a 
specific metal-bridge with Sco1 (Banci et al., 2007). These data suggest that 
the Cox172S-S form is the active state in the copper transfer within the 
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mt IMS. In contrast, the biological role of Cu4Cox170S-S is currently not clear. 
It predominantly exists in the cytosol (Palumaa et al., 2004; Voronova et al., 
2007b), as this is characterized by a more reducing environment than the 
mt IMS. Additionally, it is most likely that it retains in the cytosol, as OMM 
pores are not permeable to copper loaded proteins (Chen and Douglas, 1987). 
 
A structural and dynamical characterization of human Cox17 in its various 
functional metallated and redox states was presented by Banci et al. (2008b). 
 
 
NMR solution structure of the partially oxidized apo (apoCox172S-S) and Cu+ bound 
form (Cu1Cox172S-S) of human Cox17. Side chain packing involving hydrophobic 
residues in the metal binding surroundings is shown in blue. The cysteines residues are 
shown in yellow and the copper ion is highlighted in cyan (modified from Banci et al. 
(2008b)).  
 
The three-dimensional structure of human Cox172S-S was solved by nuclear 
magnetic resonance (NMR) spectroscopy (Figure 1.7) (Banci et al., 2008b). 
The protein exhibits a helix-turn-helix motif (‘coiled coil-helix-coiled coil-
helix’) in which the helices are connected by two parallel disulfide bonds 
preceded by a flexible and unstructured N-terminal tail. In Cox17, the twin 
Cx9C structural motif stabilizes the two antiparallel α-helices and depending 
on the redox state of Cox17, these opposing cysteine residues can be linked 
by disulfide bridges (Longen et al., 2009). Upon copper binding, structural 
and dynamical changes are induced, which are only restricted to the metal-
binding region. 
 
Figure 1.7. NMR solution structures of apo- and Cu1-Cox172S-S. 
 
apoCox172S-S                  Cu1Cox172S-S 
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1.10 AIMS OF THE THESIS 
Mitochondria require a large variety of chemical elements to perform 
biological functions and among these elements, copper is an essential redox 
metal used as a cofactor by mitochondrial COX. The coordinated assembly 
and the insertion of copper into the COX CuA and CuB active sites require the 
involvement of different chaperones. Since free copper is not available in the 
cells, a chaperone system is necessary to deliver copper to mitochondria and 
COX. Studies of COX-deficient yeast (S. cerevisiae) mutants suggest that the 
transfer of copper to mitochondria requires amongst others the evolutionary 
conserved proteins Cox17, Cox11 and two members of the Sco protein family 
for insertion of copper into COX (Khalimonchuk and Rödel, 2005). While the 
yeast proteins have been studied in detail, only few data are available on 
mammalian mitochondrial copper metabolism.  
 
The aim of this thesis is the characterization of key proteins regulating the 
mammalian mt copper metabolism, with special emphasis on Cox17. Despite 
major research on COX17 in different model systems, the exact role in the 
mammalian mt metabolism and COX assembly remains unknown. 
 
As a first step, the subcellular localization of human Cox17 is investigated in 
HeLa cells. In order to reveal the role of Cox17, RNA interference (RNAi) 
directed against COX17 is used. Knockdown efficiency is verified by qRT-PCR 
and Western blot analysis. The effects of RNAi-mediated COX17 knockdown 
are analyzed on different levels, including cell proliferation and apoptosis, 
ROS formation, enzymatic assays and oxygen consumption. Additionally, the 
effect of Cox17 depletion of the protein distribution of Cox17 and COX is 
investigated with direct stochastic optical reconstruction microscopy 
(dSTORM). The organization of respiratory chain complexes is analyzed upon 
COX17 knockdown using Blue Native (BN)-PAGE and subsequently in gel 
enzymatic activity assays (first dimension), or after separation in a SDS-gel 
(second dimension). Finally, copper supplementation experiments are 
performed to determine the potential to rescue the COX17 RNAi phenotype. 
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2 MATERIALS AND METHODS 
2.1 MATERIALS 
2.1.1 CHEMICALS AND REAGENTS 
The following chemicals and reagents were obtained from the indicated 
sources: 
 
2-Propanol AppliChem, Germany 
3,3'-Diaminobenzidine Fluka, Switzerland 
6-Aminocaproic acid Sigma-Aldrich, Germany 
Acetic acid Roth, Germany 
Acrylamide/ bisacrylamide (30 %) AppliChem, Germany 
Acrylamide/ bisacrylamide (40 %) Sigma-Aldrich, Germany 
AEBSF AppliChem, Germany 
AgaroseLE Biozym, Germany 
APSPlusOne GE Healthcare, UK 
Boric acid Roth, Germany 
BSA AppliChem, Germany 
CHAPS GE Healthcare, UK 
Chloroform Roth, Germany 
Coomassie® Brilliant Blue G250 Merck, Germany 
cytochrome c (from horse heart) Sigma-Aldrich, Germany 
DCFH-DA Sigma-Aldrich, Germany 
Di-potassium hydrogen phosphate Roth, Germany 
Digitonin AppliChem, Germany 
DMEM PAA Laboratories, Germany 
DTNB Sigma-Aldrich, Germany 
dNTP mix Promega, Germany 
EDTA Roth, Germany 
Ethanol AppliChem, Germany 
Ethidium bromide (1 µg/ml) Roth, Germany 
FBS Gold Biochrome, Germany 
Formalin solution (10 %) Sigma-Aldrich, Germany 
Galactose Sigma-Aldrich, Germany 
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GBX developer/ replenisher Sigma-Aldrich, Germany 
GBX fixer and replenisher Sigma-Aldrich, Germany 
Glucose Sigma-Aldrich, Germany 
Glutamine (stabilized) 200 mM Biochrome, Germany 
Glycerol AppliChem, Germany 
Glycine AppliChem, Germany 
HEPES PAA Laboratories, Germany 
Hydrochloric acid AppliChem, Germany 
Imidazole AppliChem, Germany 
Magnesium chloride Invitek, Germany 
2-Mercaptoethanol Roth, Germany 
Mercaptoethylamine Sigma-Aldrich, Germany 
Methanol Fisher Scientific, UK 
MOPS Sigma-Aldrich, Germany 
N-dodecyl β-D-maltoside Sigma-Aldrich, Germany 
NAD+ Sigma-Aldrich, Germany 
Neomycin (G418) PAA Laboratories, Germany 
Nitrotetrazolium blue chloride Sigma-Aldrich, Germany 
Nonfat dried milk powder AppliChem, Germany 
Normal Goat Serum Sigma-Aldrich, Germany 
Nuclease free water Applied Biosystems / Ambion,  
Germany 
Oligofectamine Invitrogen, Germany 
Opti-MEM Invitrogen, Germany 
Paraquat (Methyl viologen) Sigma-Aldrich, Germany 
PBS  PAA Laboratories, Germany 
peqGOLD TriFastTM PeqLab, Germany 
Ponceau S Roth, Germany 
Propidium iodid Sigma-Aldrich, Germany 
Protease inhibitor cocktail  Roche, Germany 
Potassium dihydrogen phosphate Roth, Germany 
Potassium hydroxide Merck, Germany 
RNase Away Nunc, Germany 
RNase-free water Qiagen, Germany 
SDS AppliChem, Germany 
Serva Blue G250 Serva, Germany 
siPORTTM XP1 Applied Biosystems / Ambion, 
Germany 
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Sodium chloride AppliChem, Germany 
Sodium hydroxide AppliChem, Germany 
Sodium pyruvate PAA Laboratories, Germany 
Sucrose Sigma-Aldrich, Germany 
TCEP Sigma-Aldrich, Germany 
TEMEDPlusOne Amersham Biosciences, Sweden 
Tricine Sigma-Aldrich, Germany 
Tris Roth, Germany 
Triton X-100 Roche, Germany 
Trypan blue stain  Invitrogen, Germany 
Tween-20 Roth, Germany 
Ultra pure ddH2O AppliChem, Germany 
 
2.1.2 ANTIBODIES 
Primary antibodies Manufacturer 
rabbit anti-Cox17  PTG, UK 
mouse MitoProfile® Total OXPHOS Human WB 
Antibody Cocktail 
MitoSciences, USA 
mouse anti-complex IV subunit I  MitoSciences, USA 
mouse anti-complex IV subunit II  MitoSciences, USA 
mouse anti-complex IV subunit IV  MitoSciences, USA 
mouse anti-complex IV subunit Va  MitoSciences, USA 
mouse anti-GAPDH Santa Cruz, Germany 
mouse anti-VDAC Santa Cruz, Germany 
  
Secondary antibodies  
donkey anti-rabbit IgG / HRP GE Healthcare, UK 
goat anti-rabbit IgG / Alexa Fluor®488 Invitrogen, Germany 
goat anti-rabbit F(AB’)2 / Alexa Fluor®647 Invitrogen, Germany 
goat anti-mouse F(AB’)2 / Alexa Fluor®647 Invitrogen, Germany 
sheep anti-mouse IgG / HRP GE Healthcare, UK 
  
2.1.3 PLASMID 
The pTurboRFP-mito plasmid was purchased from Evrogen (Germany). 
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2.1.4 KITS 
Kit Manufacturer 
CytoGLOTM Annexin V-FITC Apoptosis 
Detection Kit 
Biomol, Germany 
DC Protein Assay Bio-Rad, Germany 
ECLplus SystemTM GE Healthcare, UK 
MaximaTMSYBR Green qPCR Master  
Mix (2x) 
Fermentas, Germany 
MitoProfile® Benchtop Mitochondria  
Isolation Kit For Cultured Cells 
MitoSciences, USA 
MycoTrace PCR detection kit PAA Laboratories, Germany 
 
2.1.5 MARKER 
Marker Application Manufacturer 
100 bp DNA-ladder DNA 
gelelectrophoresis 
Roth, Germany 
HMW gel filtration calibration kit BN-PAGE GE Healthcare, UK 
NativeMarkTM unstained protein 
standard 
BN-PAGE Invitrogen, Germany 
PageRulerTM plus prestained protein 
ladder 
SDS-PAGE Fermentas, Germany 
 
2.1.6 ENZYMES 
Enzyme Manufacturer 
Catalase Roche, Germany 
CombiZyme DNA polymerase  Invitek, Germany 
DyNAzymeTMEXT DNA Polymerase Finnzymes, Finland 
Glucose oxidase Sigma-Aldrich, Germany 
Proteinase K Roth, Germany 
RNase-free DNase I  Applied Biosystems / Ambion, 
Germany 
RNase inhibitor  Promega, Germany 
SuperScript II Invitrogen, Germany 
Trypsin-EDTA (1x) PAA Laboratories, Germany 
Table 2.1. List of gel electrophoresis markers. 
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2.1.7 PRIMERS  
The listed PCR primers were synthesized by Biomers (Germany). The listed 
quantitative PCR primers were obtained from Qiagen (Germany). 
 
PCR primers Sequence (5’ → 3’) 
COX1 for: TTCGAAGCGAAGGCTTCTC 
rev: GTCCTATCAATAGGAGCTGT 
COX2 for: CGACTACGGCGGACTAATCT 
rev: TCGATTGTCAACGTCAAGGA 
ß-ACTIN for: AGAAAATCTGGCACCACACC 
rev: AGAGGCGTACAGGGATAGCA 
COX17 for: GCCGGGTCTGGTTGACTC 
rev: CTAGGGCTCTCATGCATTCC 
GAPDH for: TTGATTTTGGAGGGATCTCG 
rev: GAGTCAACGGATTTGGTCGT 
oligo (dT)12-18 primer Invitrogen, Germany 
 
qRT-PCR primers (not specified by manufacturer) 
Hs_COX17_1_SG Quantitect Primer Assay 
Hs_GAPDH_2_SG Quantitect Primer Assay 
Hs_Actin_2_SG Quantitect Primer Assay 
Hs_COX1_1_SG Quantitect Primer Assay 
Hs_COX2_2_SG Quantitect Primer Assay 
Hs_COX4I1_1_SG Quantitect Primer Assay 
 
2.1.8 SIRNAS 
The listed siRNA sequences targeting human genes were obtained from 
Applied Biosystems / Ambion, Germany. 
 
 
gene  siRNA ID/ 
number 
gene ID Sequence (5’ → 3’) 
COX17 138009 
siRNA 1 
10063 for: GCCCUAGGAUUUAAAAUAUtt 
rev: AUAUUUUAAAUCCUAGGGCtc 
COX17 16589 
siRNA 2 
10063 for: GGAGAAGAACACUGUGGACtt 
rev: GUCCACAGUGUUCUUCUCCtt 
Table 2.2. List of siRNAs.
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COX17 138010 
siRNA 3 
10063 for: CGAACUUUGAUAUGUGGAAtt 
rev: UUCCACAUAUCAAAGUUCGtc 
COX17 16681 
siRNA 4 
10063 for: GGAAUGCAUGAGAGCCCUAtt 
rev: UAGGGCUCUCAUGCAUUCCtt 
COX17 s19572 
siRNA 5 
10063 for: GAAUGAAGAAGAUUAAUUUtt 
rev:AAAUUAAUCUUCUUCAUUCtt 
COX17 s19571 
siRNA 6 
10063 for: GAACUUUGAUAUGUGGAAAtt 
rev:UUUCCACAUAUCAAAGUUCgt 
COX17 s19573 
siRNA 7 
10063 for: GUAUCAUCGAGAAAGGAGAtt 
rev:UCUCCUUUCUCGAUGAUACac 
    
negative control siRNAs  
Silencer 1 AM4635 not specified by manufacturer 
Silencer 2 AM4637 not specified by manufacturer 
    
positive control siRNAs  
Silencer GAPDH AM4631 not specified by manufacturer 
Silencer KIF11 AM4639 not specified by manufacturer 
 
 
 
 
 
Figure 2.1. Respective positions of the siRNA sequence on COX17 mRNA. 
                                                                                                       
                                                                         MATERIALS AND METHODS 
 
 28 
2.2 METHODS 
2.2.1 CELL CULTURE 
2.2.1.1 CELL CULTURE: HELA CELLS 
HeLa cells were maintained at 37 °C in a humidified atmosphere with 5 % CO2 
in galactose medium* (Reitzer et al., 1979; Rossignol et al., 2004). Cells were 
regularly checked with the MycoTrace PCR detection kit for the presence of 
mycoplasma.  
 
Galactose medium for HeLa cells: 
1 × DMEM 
10 mM Galactose 
10 % (v/v) FBS 
2 mM Stable glutamine 
10 mM HEPES 
1 mM Sodium pyruvate 
 
2.2.1.2 CELL CULTURE: HELA CELLS TRANSFECTED WITH PTURBORFP-MITO 
HeLa cells were maintained at 37 °C in a humidified atmosphere with 5 % CO2 
in selection medium.  
 
Selection medium for pTurboRFP-mito HeLa cells: 
1 × DMEM 
1 mg/ml Glucose 
10 % (v/v) FBS 
1 % (v/v) Stable glutamine 
0.4 mg/ml or 0.2 mg/ml Neomycin (G418) 
 
                                                 
* HeLa cells were grown in galactose medium, as it has been shown that mitochondrial respiration 
is stimulated in galactose medium. In contrast, when Hela cells are grown in glucose medium, 
~80 % of glucose is metabolized through glycolysis. 
                                                                                                       
                                                                         MATERIALS AND METHODS 
 
 29 
2.2.1.3 SUBCULTIVATION 
HeLa cells were trypsinized and passaged every second or third day in 
proportion of 1:4 or 1:6, respectively. For passaging, the cells were washed 
with 10 ml PBS and incubated in 3 ml trypsin-EDTA (0.5 mg/ml) for 5 min at 
37 °C. Trypsinized cells were gently resuspended by several times up/down 
pipetting in 8 ml (to 12 ml – according to the desired passaging ratio) cell 
culture medium and 2 ml were transferred into a new tissue culture flask 
containing 13 ml of cell culture medium. 
 
2.2.1.4 DETERMINATION OF CELL NUMBER 
10 µl of the cell suspension was mixed with 10 µl 0.4 % trypan blue solution 
and counted using a Neubauer hemocytometer.  
 
2.2.1.5 CELL STORAGE AND THAWING 
HeLa cells were passaged as described above, seeded in 75 cm2 cell culture 
flasks and grown until high confluence was reached. The cells were detached, 
resuspended in cell culture medium and centrifuged at 500 x g for 5 min in a 
cell centrifuge with a swing-out rotor. The supernatant was removed and the 
cell pellet was carefully resuspended at a concentration of 1 x 106 cells/1.5 ml 
of ice cold freezing medium and transferred to a cryotube. The cryotube was 
immediately stored in an isopropanol alcohol insulated container at -80 °C 
over night. After 24 h the cell aliquots are transferred and stored in the liquid 
nitrogen tank at -196 °C. 
 
In order to return the cryoconserved cell suspension from storage it was 
thawed quickly in a 37 °C water bath with constant moving. The thawed cell 
suspension was transferred to 15 ml cell culture medium and the cells were 
centrifuged for 5 min at 200 x g. The supernatant was discarded, the pellet was 
resuspended in cell culture medium and transferred to a 75 cm2 bottle, which 
was set up with 12 ml of cell culture medium before. Incubation was carried 
out at 37 °C and 5 % CO2. 
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Freezing medium: 
70 % (v/v) DMEM 
20 % (v/v) FBS 
10 % (v/v) DMSO 
 
2.2.2 TRANSIENT TRANSFECTION OF HELA CELLS 
Adherent HeLa cells were transiently transfected by liposomal transfection 
(lipofection) with Oligofectamin. The method is based on the uptake of 
complexes formed by interaction of cationic lipids with negatively charged 
DNA molecules by the cells. 
One day before transfection 30,000 (100,000; 1 Mio) HeLa cells were plated 
on 24 well (6 well; 15 cm) plates. On the day of transfection Oligofectamin 
was diluted 10 times into serum-free medium (Opti-MEM), incubated for 
5 min at room temperature (RT) and combined with 25 nM siRNA, diluted in 
Opti-MEM. Samples were incubated for 20 min at RT and finally pipetted into 
each well. Gene silencing effects were monitored after 24, 48, 72, 96, 120, 
144 h post transfection. 
 
2.2.3 TRANSFECTION OF HELA CELLS WITH PTURBORFP-MITO 
The pTurboRFP-mito vector is coding for the red fluorescent protein TurboRFP 
fused to the mt targeting sequence (MTS) derived from the subunit VIII of 
human COX (www.evrogen.com). In addition, pTurboRFP-mito mediates 
neomycin resistance for selection of successfully transfected cells. 
One day before transfection 100,000 cells were plated on a 6 well plate and 
grown until ~60 % confluence. On the day of transfection the transfection 
agent siPORTTM XP-1 was equilibrated to RT, diluted with 97 µl Opti-MEM and 
kept for 20 min at RT. 1 µg pTurboRFP-mito (0.5 µg/µl) was added in a 3:1 
proportion of transfection reagent to DNA. Sample was incubated for 20 min 
at RT and finally added to the cells. After 24 h the cells were washed with PBS 
and exposed to selection medium (0.4 mg/ml neomycin) for two weeks. 
Transfected cells that obtained neomycin resistance in the course of 
transfection appeared as individual colonies of surviving cells. For picking the 
clones, ten days post transfection, the plate was rinsed with 10 ml PBS. 
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Sterile 3 mm cloning disks (Sigma-Aldrich) were soaked in trypsin-EDTA and 
carefully placed on each colony, using sterile forceps. After 3 min the disks 
were transferred into the wells of a 48 well plate already containing 300 µl 
selection medium. Clones that showed a satisfactory growth after 
approximately 3 days were detached from the wells by incubation with 50 µl 
typsin-EDTA and transferred to 6 well plates containing 2 ml selection 
medium. Cells that reached 90 % confluence were splitted into 75 cm² cell 
culture flask and were cultivated in selection medium with a reduced amount 
of neomycin (0.2 mg/ml). 
 
2.2.4 IMMUNOCYTOCHEMISTRY  
1x105 HeLa cells transfected with pTurboRFP-mito were grown on 70 mm2 
glass chamber slides (BD Falcon, CA), fixed with formalin-PBS (10 %) for 
10 min at 4 °C, and transferred into pre-chilled acetone (-20 °C) for 5 min. 
Subsequently, the cells were incubated with 10 % (w/v) bovine serum 
albumin in PBS for 1 h at 37 °C to block non-specific binding. 
Immunocytochemical detection was then performed with a polyclonal Cox17 
antibody (1 µg/ml) and with a secondary rabbit IgG Alexa Fluor® 488 antibody 
(1:500). Images were acquired using a confocal inverse Leica SP 5 
(DM 6000B) microscope equipped with a multi-photon laser and a HCX PL 
APO 63 x objective (1,4 - 0,6 Oil, Lbd.Bl.). The 488 nm and 561 nm laser 
lines and appropriate 515 (±15) and 590 (±15) nm band pass filter sets were 
used for excitation and fluorescence detection, respectively. Individual 
channel images were acquired separately. 
 
2.2.5 RNA EXTRACTION AND QUANTITATIVE REAL-TIME PCR 
Cells were rinsed with PBS and total RNA was isolated from HeLa cells using 
peqGOLD TriFast according to the manufacturers instructions. Finally RNA was 
eluted in 20 µl RNase-free water. To remove residual DNA, 2 µl 10 x DNase 
buffer (0.4 M Tris, 0.1 M NaCl, 50 mM MgCl2 in RNAse-free water, pH 7.4) and 
2 µl RNase-free DNase I (2 U/µl) were added to the RNA solution and 
incubated at 37 °C for 30 min, then at 65 °C for 20 min, cooled on ice and 
collected by brief centrifugation. Purity of RNA was assessed by the ratio of 
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the absorbance A260/A280 in a Nanodrop spectrophotometer (PeqLab).  
For reverse transcription, 1 µg total RNA, 2 µl RT buffer, 4 µl 25 mM MgCl2, 
1 µl dNTP mix, 1 µl oligo (dT)12-18 primers, and 1 µl RNAse inhibitor were 
added to water to a total volume of 10 µl. Before adding the reverse 
transcriptase, 1 µl was removed from each sample and mixed with 9 µl water, 
to be used as a non-template control during RT-PCR. 1 µl SuperScript™II 
reverse transcriptase was added to each sample tube and reverse 
transcription was carried out at 42 °C for 50 min. The reaction was 
terminated at 70 °C for 15 min.  
 
Semi-quantitative RT-PCR was performed with 1 µl of the cDNA template in a 
total volume of 25 µl of amplification buffer, 10 pmol of specific primers and 
0.4 units of CombiZyme DNA polymerase using the following parameters: 
initial denaturation at 94 °C (5 min) followed by 30 cycles of 30 sec at 94 °C 
and 30 sec at 48 °C and 30 sec at 72 °C elongation. Primers are listed in 
chapter 2.1.7. Amplified RT-PCR products were separated on a 1.5 % agarose 
gel and visualized by staining with ethidium bromide. The house-keeping 
genes β-actin or GAPDH were used for normalization.  
For quantitative real-time PCR, 10 µl cDNA were mixed with 2.5 µl 
10 x primer mix and 12.5 µl 2x SYBR Green qPCR MasterMix. qRT-PCR was 
carried out on a Mastercycler®ep realplex instrument (Eppendorf) using an 
initial denaturation at 95 °C (10 min) followed by 40 cycles of 30 sec at 95 °C 
and 15 sec at 60 °C and 15 sec at 72 °C elongation. The house-keeping genes 
β-actin or GAPDH were used for normalization.  
 
2.2.6 ISOLATION OF MITOCHONDRIA 
Isolation of mitochondria and solubilization of OXPHOS complexes was 
basically performed according to Schägger (1996). In brief, 1-2 x 106 HeLa 
cells were collected with a cell lifter, pelleted by centrifugation at 1,000 x g 
and stored at -80 °C before continuing cell lysis.  
 
2.2.6.1 ISOLATION OF MITOCHONDRIA FOR BN-PAGE ANALYSIS 
According to the manufacturers protocol (MitoProfile Benchtop Mitochondria 
Isolation Kit for Cultured Cells, MitoSciences) cells were thawed on ice, 
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resuspended in 5 mg/ml reagent A and incubated for 10 min on ice. The cells 
were transferred in a pre-cooled 2 ml Dounce Homogenizer (MitoSciences) 
and homogenized with 50 strokes using pestle B. After centrifugation at 
1,000 x g for 10 min at 4 °C the supernatant was saved and procedure was 
repeated using reagent B. Mitochondria were then pelleted from the 
supernatants (12,000 x g, 15 min, 4 °C) and resuspended in 12 µl lysis buffer 
(50 mM NaCl, 5 mM 6-aminocaproic acid, 50 mM imidazole, 1 mM AEBSF, 
1x protease inhibitor cocktail (PIC) and 8 µl 10 % digitonin (in lysis buffer). 
After 15 min incubation on ice, the samples were centrifuged (18,000 x g, 
15 min) and 5 µl coomassie-free loading buffer (10 % glycerol, 0.01 % 
Ponceau S) were added to the supernatant. Samples were subsequently 
loaded onto a 3-13 % polyacrylamide (PAA) gradient gel including a 3 % 
spacer gel.  
 
2.2.6.2 ISOLATION OF MITOCHONDRIA FOR LOCALIZATION STUDIES 
According to Schägger (1996) cells were thawed on ice, resuspended in 
500 µl hypotone buffer (83 mM sucrose, 10 mM MOPS, pH 7.2) and 
homogenized in a glass/glass pestle with 50 strokes before 500 µl CL 1 buffer 
(250 mM sucrose, 30 mM MOPS, pH 7.2) were added. Cell debris was 
collected by centrifugation (600 x g, 15 min) and the procedures were 
repeated. Mitochondria were then pelleted from the supernatants (15,000 x g, 
15 min, 4 °C) and resuspended in CL 1 buffer. Protein concentration was 
measured using the DC Protein Assay. Samples were dissolved in SDS-PAGE 
sample buffer containing 50 mM TCEP by incubation for 7 min at 45 °C and 
separated on 15 % PAA gels. 
 
2.2.6.3 ISOLATION OF BOVINE HEART MITOCHONDRIA 
20 mg bovine heart was homogenized with 250 µl buffer M (440 mM sucrose, 
20 mM MOPS, 1 mM EDTA, pH 7.2) in a glass/glass pestle. Mitochondria were 
pelleted (20,000 x g, 20 min, 4 °C) and resuspended in 40 µl lysis buffer 
(50 mM NaCl, 5 mM 6-aminocaproic acid, 50 mM imidazole, 1mM AEBSF, 1 x 
PIC) and 15 µl 10 % digitonin (in lysis buffer). After 15 min incubation on ice, 
the samples were centrifuged (18,000 x g, 15 min) and 5 µl Coomassie-free 
loading buffer (10 % glycerol, 0.01 % Ponceau S) were added to the 
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supernatant. Samples were subsequently loaded onto a 3-13 % PAA gradient 
gel including a 3 % spacer gel.  
 
2.2.7 PROTEINASE K TREATMENT OF MITOCHONDRIA AND 
MITOPLASTS 
For mitoplast formation 20 µg of mitochondria were incubated in ice-cold 
hypotonic buffer (10 mM Tris/HCl, pH 7.4, 1 mM EDTA, 10 mM MOPS, 50 mM 
sucrose), and incubated for 30 min on ice. Mitoplasts were stabilized by the 
addition of one volume buffer containing 250 mM sucrose. Proteinase K was 
added to a final concentration of 10 µg/ml to either mitochondria or 
mitoplasts in the presence or absence of 1 % Triton X-100. Samples were 
incubated for 15 min on ice, and the reaction was stopped by the addition of 
PIC (1:50) and AEBSF to a final concentration of 1 mM. The pellet obtained by 
centrifugation (18,000 x g for 10 min at 4 °C) was subjected to SDS-PAGE.  
 
2.2.8 PHOTOMETRIC ACTIVITY ASSAY 
2.2.8.1 CITRATE SYNTHASE ACTIVITY  
Citrate synthase (CS) was determined spectrophotometrically at 25 °C by 
measuring the concentration of the CoA-SH at 412 nm. Sample mixture was 
prepared by adding of 10 µl oxaloacetate (10 mM in TE, pH 8), 30 µl acetyl-
CoA (5 mM in TE, pH 8), 10 µl DTNB (10 mM in 1 M Tris/HCL, pH 8) to a total 
volume of 200 µl TE buffer (50 mM Tris/HCl, 2 mM EDTA, pH 8). 10 µg of 
isolated mitochondria were used to start the reaction. Readings were taken at 
20 s intervals for 2–2.5 min to measure acetyl-CoA deacylase activity. 
 
The reaction is described as follows: acetyl-CoA + oxaloacetate + H2O ↔ 
citrate + CoA-SH + H+ (side reaction: CoA-SH + DTNB → mercaptide ion) and 
the activity is calculated according to: 
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E * min-1  = increase in absorbance per min 
ε (DTNB)  = absorption coefficient at 412 nm [13.6 * (mM * cm)-1] 
Cmito   = mitochondria concentration [mg*ml-1] 
d   = optical path of the cuvette [cm] 
 
2.2.8.2 CYTOCHROME C OXIDASE ACTIVITY  
COX activity of isolated mitochondria, normalized to the activity of CS was 
photometrically measured as described by Tzagoloff et al. (1975). To this end, 
cytochrome c was prepared by reduction with DTT, purified by de-salting on a 
PP-10 column (GE Healthcare) and reoxidized by active COX. The extent of 
reduction of cytochrome c was determined by measuring the differences in 
absorbance at 550 nm. 
Mitochondria were solubilized in assay buffer (50 mM potassium phosphate 
buffer, pH 7.2, 0.5 % (v/v) Tween) and COX reaction was started by addition 
of ferrous cytochrome c (final concentration 120 µM). The initial fast reaction 
rate was measured at RT by monitoring the decrease in absorbance at 
550 nm during the first 60 s of the reaction. Specificity of the measurement 
was obtained by adding of ferrocyanide, a specific inhibitor of COX. 
 
The absorption A550/min was calculated using the maximum linear rate for 
both the sample and the blank. The activity of the samples was calculated 
according to a first-order reaction with respect to the COX concentration:   
 
 
 
E * min-1 
ε (DTNB) * Cmito *d 
activity   = 
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ΔA/min    = A/min (sample) – A/min (blank)  
Vol (sample)    = volume of sample in ml  
0.2     = total assay volume is 1 ml  
dilution    = dilution factor of the sample (= 0.2 ml / Vol (sample) )  
Δε (cytochrome c)  = extinction coefficient between ferroctyochrome c and    
ferricytochrome c at 550 nm [21.84 mM] 
 
Unit definition: one unit oxidizes one µmole of ferrocytochrome c per minute 
at 25 °C, pH 7.0.  
 
2.2.9 BLUE NATIVE POLYACRYLAMIDE GEL ELECTROPHORESIS   
(BN-PAGE) 
BN-PAGE originally established by Schägger and von Jagow (1991) was 
performed for separation of OXPHOS complexes. 200 µg isolated mitochondria 
were pelleted (15,000 x g, 15 min, 4 °C) and resuspended in 12 µl 50 mM 
NaCl, 5 mM 6-aminocaproic acid, 50 mM imidazol, pH 7.0 supplemented with 
PIC and digitonin (detergent:protein ration of 4:1 g/g) for 15 min on ice. The 
samples were centrifuged (18,000 x g, 10 min), and 5 µl of Coomassie-free 
loading buffer (5 % glycerol, 0.01 % Ponceau S) were added to the 
supernatant. Subsequently, the samples were loaded onto 3-13 % PAA 
gradient gel including a 2.5 % spacer gel. The NativeMark™ unstained protein 
standard and the high molecular weight gel filtration calibration kit 
(thyroglobulin mono-/dimer: 669/1,300 kDa, ferritin: 440 kDa, aldolase: 
158 kDa) were used as molecular weight markers. Gels were run in a vertical 
electrophoresis apparatus Hoefer SE 600 Ruby (GE Healthcare) with a gel size 
of 18 x 16 cm. Gel electrophoresis was started in the presence of anode buffer 
(25 mM Imidazol, pH 7.0) and cathode buffer A (50 mM Tricine, 7.5 mM 
Imidazol, 0.02 % (w/v) Serva Blue G 250, pH 7.0) with a change to cathode 
buffer B (50 mM Tricine, 7.5 mM Imidazol, 0.002 % (w/v) Serva Blue G 250, 
 Vol (sample) * Δε (cytochrome c)  
 ΔA/min * dilution * 0.2 
Unit/ml   = 
                                                                                                       
                                                                         MATERIALS AND METHODS 
 
 37 
pH 7.0) after approximately ½ of the gel run.  
 
2.2.9.1 IN GEL ACTIVITY ASSAY  
Complex I specific activity was determined after 30 min equilibration in 
buffer I (2 mM Tris/HCL, pH 7.4) and subsequent incubation at 30 °C in the 
presence of buffer I containing 2.5 mg/ml nitro tetrazolium blue (NTB) and 
0.1 mg/ml NADH (Tzagoloff et al., 1975; Suthammarak et al., 2009). For 
complex IV activity, gels were equilibrated for 1 h at 30 °C in buffer IV 
(50 mM potassium phosphate, pH 7.4, 75 mg/ml sucrose), followed by 
incubation at 30 °C in the presence of buffer IV containing 5 mM 
cytochrome c (Wittig and Schägger, 2007). Lactate dehydrogenase (LDH) 
specific activity was examined after 1 h equilibration in LDH assay buffer 
(10 mM Tris/HCL, 10 mM lactic acid, pH 8) and subsequent incubation at 
30 °C in the presence of LDH assay buffer containing 3 mM NAD+, 0.75 mM 
NTB and 0.05 mM phenazine methosulfate (PMS). 
 
2.2.9.2 2D-BN/SDS-PAGE 
For separation of individual complex subunits in a second dimension, strips 
from the first dimension BN-PAGE were sliced, and proteins were denatured 
by incubation for 30 min at RT in 1 % SDS containing 5 mM TCEP. The second 
dimension gel electrophoresis was carried out in the MiniVE-system 
(GE Healthcare) using 12 % SDS-gels. Proteins were transferred onto a 
polyvinylidene difluoride (PVDF) membrane using a semi-dry blot system and 
probed with primary antibodies directed against Cox17, VDAC, Cox1, and 
complex I subunit NDUFB8, complex II 30 kDa-subunit, complex III subunit 
Core 2, complex IV subunit II, and ATP synthase subunit alpha, which are 
components of the total OXPHOS human antibody cocktail. Proteins were 
detected with horseradish peroxidase (HRP)-conjugated IgG secondary 
antibody and the ECLplus kit.  
 
2.2.10 SDS-PAGE AND WESTERN BLOT ANALYSIS 
Total protein was extracted from cells using lysis buffer (10 mM Tris-HCl, 
10 % glycerol, 1 % SDS and 1 % CHAPS) with PIC for 30 min on ice. The cell 
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lysate was cleared by centrifugation at 20,000 x g for 10 min. Protein 
concentration was measured using the DC Protein Assay. Samples were 
dissolved in SDS-PAGE sample buffer containing 50 mM TCEP by incubation 
for 7 min at 45 °C and separated on 15 % PAA gels. Proteins were transferred 
onto a PVDF membrane using a semi-dry blot system. Blocking was 
performed for 1 h at RT or overnight at 4 °C in TBS supplemented with 0.1 % 
Tween and 5 % milk powder. Incubation with both primary (Cox17, VDAC, 
Cox1, Cox2, Cox4, Cox5 and Total OXPHOS human antibody cocktail) and 
secondary antibodies were performed at RT for 1 h, respectively, in the same 
solution as for the blocking. After each antibody incubation, blots were 
washed 3 x 10 min with TBS supplemented with 0.1 % Tween. Signals were 
detected using the ECLplus kit. 
 
2.2.11 DIRECT STOCHASTIC OPTICAL RECONSTRUCTION 
MICROSCOPY (DSTORM) 
dSTORM (Heilemann et al., 2008) of COX17 siRNA transfected HeLa cells 
labeled with Alexa Fluor 647 was performed on an Olympus IX-71 inverted 
microscope applying an objective-type total internal reflection fluorescence 
(TIRF) configuration using an oil-immersion objective (PlanApo 60×, NA 1.45, 
Olympus) (van de Linde et al., 2008). Two continuous wave laser beams 
(647 nm and 488 nm) of an argon–krypton laser (Innova 70C, Coherent) 
were selected by an acousto-optic tunable filter (AOTF) and used 
simultaneously for read-out and activation. The fluorescence was imaged on 
an EMCCD camera (Andor Ixon DU888) (Heilemann et al., 2008).  
Indirect immunocytochemistry was applied to stain Cox17 and COX of 
pTurboRFP-mito transfected HeLa cells. The cells were fixed using 3.7 % 
paraformaldehyde in PBS for 10 min. Afterwards, cells were washed and 
permeabilized in blocking buffer (PBS containing 5 % w/v normal goat serum 
and 0.5 % v/v Triton X-100) for 10 min.  
Cox17 were stained with rabbit polyclonal anti-Cox17 antibodies and with 
Alexa 647-labeled goat anti-rabbit F(ab’)2 fragments serving as secondary 
antibody. COX were stained with mouse monoclonal anti-complex IV subunit I 
and with Alexa 647-labeled goat anti-mouse F(ab’)2 fragments serving as 
secondary antibody, both for 60 min. Three washing steps using PBS 
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containing 0.1 % v/v Tween 20 were performed after each staining step. Prior 
to the dSTORM measurement, the PBS buffer in the fixed cell samples was 
replaced by switching buffer (PBS, pH 7.4, containing oxygen scavenger 
(oxygen was removed adding 0.5 mg/ml glucose oxidase, 40 µg/ml catalase, 
10 % glucose and 50 mM β-mercaptoethylamine)). Laser powers used for 
dSTORM imaging were 0.02–0.5 kW/cm2 at 488 nm and 4–26 kW/cm2 at 
647 nm with frame rates of 50–200 Hz recording 10,000–15,000 images with 
total acquisition times of 50–200 s (van de Linde et al., 2008). Fluorescent 
spots were identified in each image frame applying an intensity threshold, and 
were fit to a Gaussian function to determine their centers of mass (van de 
Linde et al., 2008).  
 
2.2.12 FLOW CYTOMETRIC PHENOTYPING 
The analysis were performed using a CyFlow®SL flow cytometer (Partec) 
equipped with an argon ion laser tuned at 488 nm with the FL1 (527 ± 15 nm) 
and FL2 (590 ± 25 nm) channels set for detection of the following 
parameters.  
 
2.2.12.1 DETERMINATION OF CELL CYLE PHASE 
Propidium iodide (PI) staining of DNA in permeabilized cells and its detection 
by flow cytometry is widely used to determine the percentage of cells in each 
phase of the cell cycle. Because PI intercalates in double-stranded DNA, the 
fluorescent intensity of a stained cell is directly proportional to the DNA 
content of the cell. For the determination of the cell cycle, 1 x 106 cells in 
0.5 ml PBS were fixed with 0.5 ml 70 % ice-cold ethanol for 20 min and 
centrifuged at 1,000 rpm for 5 min. The pellet was resuspended in 0.5 ml of 
PI-RNase solution (50 µg/ml PI, 100 µg/ml RNase) and incubated for 20 min 
at RT in the dark. Cells were analyzed by flow cytometry using the FL2 
channel for PI. Quantitative G1, S and G2/M peaks were identified in an one 
parameter DNA histogram by the peak fitting program of the Partec FloMax® 
FCM Data Acquisition and Analysis software (Figure 2.2).  
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Peak fitting to model the PI data was performed automatically using the modelling 
program of the Partec FloMax® FCM Data Acquisition and Analysis Software. In the 
image a typical cellular state with the majority of cells in the G0/G1 phase (blue) can 
be seen. The rightmost peak on the histogram shows the cells in the G2/M state 
(green). The area between these peaks indicates cells within S-phase (red). 
 
2.2.12.2 IDENTIFICATION OF APOPTOTIC CELLS 
To discriminate viable from apoptotic and dead cells, a double staining of 
HeLa cells with Annexin V-FITC and PI was used (Chen et al., 2008). During 
apoptosis, phosphatidylserine (PS) normally found on the inner leaflet of the 
plasma membrane, is translocated to the outer leaflet. Thereby, PS is exposed 
at the external surface of the cell. Annexin V is a 36 kDa Ca2+ dependent 
binding protein that has high affinity and selectivity for PS. The measurement 
of Annexin V-FITC binding to the cell surface is performed in conjunction with 
the vital dye PI to distinguish between non-apoptotic (Annexin V-FITC 
negative / PI negative), early apoptotic (Annexin V-FITC positive / PI 
negative) and late apoptotic or necrotic cells (Annexin V-FITC positive / PI 
positive) (Figure 2.3). 
 
Figure 2.2. Quantification of cell cycle distribution of HeLa cells.
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The cell populations in the lower left quadrants represent non-apoptotic cells (viable), 
in the lower right quadrants early apoptotic cells (apoptotic) and in the upper right 
quadrants late apoptotic or necrotic cells (necrotic). 
 
For the identification of apoptotic cells, cultured cells were collected by 
centrifugation and washed once with cold PBS, centrifuged and resuspended 
in binding buffer (according to the manufacturer protocol). 100,000 cells were 
incubated together with 5 µl Annexin V-FITC and 5 µl PI for 20 min at RT in 
the dark. Cells were analyzed by flow cytometry using the FL1 and FL2 
channels for detecting Annexin V-FITC and PI staining, respectively. For each 
measurement 20,000 events were collected, and cells were gated as viable, 
apoptotic and necrotic based on both their light scatter signals. Data were 
analyzed using Partec FloMax® FCM Data Acquisition and Analysis Software. 
 
2.2.12.3 DETECTION OF ROS 
Intracellular reactive oxygen species (ROS) generation was investigated using 
the cell-permeable fluorogenic probe 2', 7'-Dichlorodihydrofluorescin diacetate 
(DCFH-DA). In brief, DCFH-DA is diffused into cells and is deacetylated by 
cellular esterases to non-fluorescent 2’, 7’-Dichlorodihydrofluorescin (DCFH), 
which is rapidly oxidized to highly fluorescent 2’, 7’ Dichlorodihydrofluorescein 
(DCF) by ROS (LeBel et al., 1992; Gomes et al., 2005; Eruslanov and 
Kusmartsev, 2010). The fluorescence intensity is proportional to the ROS 
levels within the cell cytosol. 
 
Figure 2.3. Sample data using Annexin V-FITC Apoptosis Detection Kit. 
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To this end, 50 µM DCFH-DA in ethanolabs were added to 1x106 cells in 1 ml 
PBS and incubated for 15 min at 37 °C in the dark. Cells were washed with PBS 
and analyzed by flow cytometry using the FL1 channel.  
 
Untreated HeLa cells (WT) treated with 20 mM paraquat for 12 h at 37 °C and 
5 % CO2 were used as ROS positive control (Bus and Gibson, 1984) 
(Figure 2.4). 
 
 
  
HeLa cells were cultivated for 12 h at 37  C and 5 % CO2 with 20 mM paraquat. Cells 
were detached with trypsin, washed with PBS and incubated with 50 µM DCFH-DA in 
ethanolabs for 15 min at 37 °C in the dark. Cellular ROS induction was analyzed by flow 
cytometry using the FL1 channel. Right: 0 mM paraquat, left; 20 mM paraquat. RN2 
gated cells represent cellular ROS levels. A total of 10,000 cells were counted for each 
sample. 
 
2.2.13 OXYGEN MEASUREMENT 
Monitoring of oxygen (O2) concentration in cell culture was done by optical-
chemical sensing. To this end, one day before transfection 30,000 HeLa 
cells /ml were plated in PreSens (OxoDish®) 24 well plates. The OxoDish®, 
which contains a polymeric oxygen sensor at the bottom of each well, was 
placed on the SensorDish reader (PreSens Precision Sensing GmbH, Germany) 
in the incubator. The sensor dish software provided a continuous visual 
display of dissolved O2 data. The software was set to take readings of 
dissolved O2 at 60 min intervals. 
Figure 2.4. DCF fluorescence in HeLa cells.
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To check that oxygen consumption was cyanide-sensitive, and thus related to 
mt activity, the respiration rates were monitored in cells exposed to 1 mM 
cyanide.  
 
2.2.14 CU–HIS SUPPLEMENTATION  
To investigate the effect of supplementation of copper ions, copper were 
added to the culture medium of COX17 siRNA and negative control siRNA 
transfected cells, as copper–histidine (Cu-His) complex (1:2 molar ratio).   
Cu–His was prepared according to the protocol of Kreuder et al. (1993) and 
stored at –80 °C at a stock concentration of 2 mg Cu–His/ml/vial. These 
preparations were used for a maximum of three months. 
Several final concentrations of copper (1, 15, 50, 75, 100, 150, 200 and 
300 µM) were added to the cells one day before transfection, 24 h or 72 h 
post transfection. The cells were incubated for at least another 24 h up to 
144 h after transfection.  
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3 RESULTS 
The general goal of this thesis is to get more insights into pathways and 
responsible proteins for delivering copper to the cytochrome c oxidase during 
its maturation. For this purpose a reverse genetic approach is used that 
consists of gene silencing by RNAi followed by a variety of assays to measure 
the RNAi effect. 
 
3.1 SUBCELLULAR LOCALIZATION OF COX17  
Yeast COX17 was the first accessory factor that has been implicated in the 
delivery of copper to the CuA and CuB centers of COX via the copper-binding 
proteins Sco1 (Glerum et al., 1996b) and Cox11 (Horng et al., 2004), 
respectively. Cox17 has been reported to possess a dual intracellular 
localization in the cytosol and the mt IMS (Glerum et al., 1996a). Human 
Cox17 is mainly localized in mitochondria (Suzuki et al., 2003; Di Fonzo et al., 
2009).  
To investigate the subcellular and submitochondrial localization of Cox17 in 
HeLa cells, mitochondria and cytoplasm of 3 x 107 cells were isolated. The 
mitochondria were purified and mitoplasts were generated (materials and 
methods 2.2.7). After incubation of the mitochondria and mitoplasts with or 
without proteinase K in the presence or absence of the detergent Triton X-100 
(Figure 3.1 (a)), proteins were separated in a 15 % SDS-PAA gel and blotted 
onto a PVDF membrane. The purity of the isolated fractions was assessed by 
detection of cytoplasmic translation initiator factor eIF-4E, the IMM COX 
subunits Cox2 and Cox5a, the soluble mt matrix heat shock protein Hsp60 
and the mt IMS protein cytochrome c. A small portion (~10 %) of Hsp60 is 
found in the cytoplasm, in accordance with the data of Gupta and Knowlton 
(2002).  
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(a) Mitochondria and mitoplasts were treated with 10 µg/ml of proteinase K in the 
presence or absence of 1 % Triton X-100. Proteins of cytoplasm, mitochondria and 
mitoplasts were separated by SDS-PAGE and detected with antibodies directed against 
Cox17. Specificity of the fractionation was tested with marker proteins of the 
cytoplasm (eukaryotic translation initiation factor 4E, eIF-4E), the mt matrix (heat 
shock protein 60, mtHsp60), the mt IMS (cytochrome c), and the IMM (COX subunits 2 
(Cox2) and 5a (Cox5a)). (b) HeLa cells expressing pTurboRFP-mito (1) were fixed, 
permeabilized, incubated with polyclonal Cox17 antibody and subsequently labeled 
with an anti-rabbit IgG Alexa Fluor®488 antibody (2). The fluorescence images were 
recorded with a confocal inverse Leica SP 5 microscope and superimposed (3). 
 
Cox17 was detected both in the cytosolic and the mt fraction, with a clear 
enrichment (~80 %) in the latter fraction. Upon treatment of intact 
mitochondria with proteinase K, Cox17 proved to be resistant as did the mt 
marker proteins. When mt membranes were solubilized with Triton X-100 
Figure 3.1. Localization of human Cox17.  
(a) 
(b) 
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Cox17 was completely digested, documenting that the protein per se is 
sensitive to proteinase K. After the formation of mitoplasts by hypo-osmotic 
treatment, Cox17 was degraded in presence of proteinase K, and thus 
behaves like the mt IMS marker cytochrome c. In contrast, the matrix protein 
Hsp60 and the IMM proteins Cox2 and Cox5a were still detectable.  
These data show that Cox17 has a dual localization, with the majority in the 
mt IMS and a small portion in the cytoplasm. The dual localization of Cox17 
was further confirmed by confocal fluorescence microscopy (Figure 3.1 (b)). 
To this end, HeLa cells that express pTurboRFP-mito (Figure 3.1 (b1)) were 
immunocytochemically labeled with polyclonal Cox17 antibody and 
subsequently incubated with an anti-rabbit IgG Alexa Fluor®488 antibody 
(Figure 3.1 (b2)). The individual channel fluorescence images were acquired 
separately using a confocal inverse microscope (Leica SP 5) and 
superimposed (Figure 3.1 (b3)). Cox17 signals mainly appeared in the well-
known structure of the mt network, and few spots were visible in the 
cytoplasm. Fluorescence of Cox17 and pTurboRFP-mito merged almost 
completely, confirming the mainly mt localization of Cox17.  
 
3.2 TRANSIENT KNOCKDOWN OF COX17 IN HELA CELLS 
Expression of COX17 in HeLa cells was transiently silenced with seven pre-
designed siRNAs. The efficiency was tested by performing individual transient 
transfection, RT-PCR and Western blot analysis.  
Appropriate controls are essential for RNAi experiments. In this assay KIF11 
(Eg5) and GAPDH were chosen as positive transfection controls. Eg5 encodes 
a motor protein that belongs to the kinesin-like protein family involved in 
chromosome positioning and bipolar spindle formation during mitosis 
(Valentine et al., 2006). Depletion of Eg5 results in mitotic arrest. Thus, cells 
treated with KIF11 siRNA appear rounded rather than flat, giving a visual 
indicator of successful siRNA delivery. The GAPDH siRNA sequence targets the 
5' medial region of the GAPDH mRNA sequence. GAPDH mRNA level in 
transfected and non-transfected cells were determined by RT-PCR using total 
RNA isolated 48 h after transfection. GAPDH siRNA reduced the expression of 
GAPDH by ~90 % (data not shown). As negative controls, mock transfection 
(transfection reagent only) as well as transfection with negative siRNAs 
(negative control siRNAs S1 and S2), which do not target any gene in the 
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genome, were used. Negative transfection controls have been tested and 
shown to have no significant impact on cell proliferation, apoptosis, or cell 
morphology (Figure 3.2). 
 
 
 
48 h upon siRNA treatment the percentage of viable cells was calculated by trypan 
blue dye exclusion. HeLa cells were transfected with 4 µl Oligofectamin and 25 nM 
siRNA per well of a 6 well plate. Mean values of triplicates are given. Error bars 
indicate the resulting standard error of the mean (SEM). 
 
Upon Eg5 depletion approximately 15 % of HeLa cells were left. Control siRNA 
(negative siRNA 1 and siRNA 2) and mock transfected cells showed hardly any 
side effects.  
 
3.2.1 KNOCKDOWN OF COX17 MRNA 
HeLa cells were transfected with siRNA triplicates in 6 well plates following the 
procedure described in materials and methods, chapter 2.2.2. Control 
transfection of two positive controls (Eg5 and GAPDH) and three negative 
controls (S1, S2, mock) were performed in parallel. After the indicated time 
points, cells were harvested, the RNA was isolated and transcribed into cDNA. 
To analyze the abundance of COX17 mRNA a semi-quantitative RT-PCR was 
employed. Briefly, cDNAs of COX17 siRNA transfected and negative control 
siRNA transfected cells were amplified with COX17 specific primers for 
30 cycles. To define the optimal number of PCR cycles for linear amplification, 
Figure 3.2. siRNA transfection efficiency in HeLa cells.  
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an aliquot from each of the samples was taken at cycle eleven, and thereafter 
at every fourth further cycle. The human GAPDH, COX1, COX2 and COX4 
specific primers were used in control reactions. The amplification products 
were analyzed by agarose gel electrophoresis (Figure 3.3 (a)).  
 
 
 
(a) COX17 mRNA was analyzed at the indicated time points by semi-quantitative RT-
PCR in cells treated with either negative- or COX17 siRNA 2. The mRNA levels of 
GAPDH, of the two mt encoded subunits COX1 and COX2, and of one nuclear encoded 
subunit COX4 were monitored as control. (b) Quantitative RT-PCR. Percent gene 
expression was calculated in COX17 siRNA transfected cells normalized to GAPDH and 
compared to those transfected with negative control siRNA transfected cells normalized 
to GAPDH. Values represent average fold changes of three experiments and error bars 
correspond to the resulting SEM. 
 
The effect of siRNA-mediated knockdown was specific: while the levels of 
control mRNAs remained constant, the COX17 mRNA level was decreased to 
Figure 3.3. Transient knockdown of COX17 mRNA.
(a) 
(b) 
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15 % after 24 h, and started to increase again after 96 h. 80 % of the 
negative control was reached 144 h post transfection.  
A slightly more pronounced decrease in COX17 transcript levels was observed 
by quantitative RT-PCR (Figure 3.3 (b)). High reproducibility was observed 
between the triplicates. 
 
3.2.2 KNOCKDOWN OF COX17 PROTEIN 
The expression of Cox17 was determined by Western blotting and 
immunodetection to confirm the RT-PCR results. As described above, HeLa 
cells were transfected with COX17 siRNAs and control siRNAs in triplicates in 
6 well plates. After the indicated time points, cells were harvested and total 
protein was extracted according to materials and methods, chapter 2.2.10.  
 
 
For Western blot analysis, 20 µg of total cell lysates from control- or COX17 siRNA 2 
transfected cells were detected with antibodies against Cox17 and VDAC, an OXPHOS 
Human Antibody Cocktail (which recognizes individual subunits of the indicated 
OXPHOS complexes), and with antibodies against Cox1, Cox4 and Cox5a. Only the 
result of COX17 siRNA 2 treatments is shown, the other COX17 siRNAs yielded similar 
results. 
 
The Cox17 antibody recognized a single band with an estimated size of 
approximately 7-12 kDa. This is in accordance with published data (Miyayama 
Figure 3.4. Effect of transient knockdown of COX17 in HeLa cells. 
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et al., 2009) and the calculated molecular weight of 6.9 kDa 
(UniProtKB/Swiss-Prot Q14061). The OMM protein VDAC was used as a 
normalization control of the samples and documented the specificity of the 
knockdown effect. Furthermore, results of the immunodetection could be 
compared directly to the RT-PCR results, since for each timepoint the same 
sample was used for both analyses.  
 
As expected, HeLa cells transfected with COX17 siRNA 2 showed a substantial 
reduction in Cox17 protein levels (Figure 3.4). 24 h post transfection the signal 
of Cox17 was essentially undetectable. As for the COX17 mRNA a recovery of 
the Cox17 protein could be observed after 96 h, which reaches the initial 
concentration after 144 h.  
 
3.2.3 EFFECT OF COX17 KNOCKDOWN ON THE STEADY-STATE 
LEVELS OF OXPHOS SUBUNITS 
The effect of COX17 knockdown on the steady-state levels of OXPHOS 
subunits was tested by use of the total OXPHOS human antibody cocktail 
(MitoScience). This cocktail is suitable for simultaneous analysis of the five 
OXPHOS complexes, as it comprises antibodies directed against complex I 
subunit NDUFB8, the 30 kDa complex II subunit, the core 2 subunit of 
complex III, subunit Cox2 of complex IV, and the α-subunit of complex V. The 
monoclonal antibodies in the cocktail are directed against subunits that are 
labile when the respective complex is not assembled (www.mitosciences.com) 
(Taanman et al., 1996).  
 
In no case the negative control siRNA had an effect on the concentrations of 
the analyzed proteins (Figure 3.4). In contrast, subunit Cox2 of complex IV 
became strongly reduced in COX17 siRNA transfected cells, reaching its 
minimal level at 72 h. In addition, the steady-state concentration of complex I 
subunit NDUFB8 seems to be slightly decreased at 48 h and 72 h, while the 
steady-state levels of complex II, III and V subunits were unaffected.  
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3.2.4 EFFECT OF COX17 KNOCKDOWN ON THE STEADY-STATE 
LEVELS OF COPPER-BEARING COX SUBUNITS  
To test whether the effect of Cox17 depletion on COX is specific for Cox2 or 
results in a reduced steady-state concentration of all or a subset of the COX 
subunits, the copper-bearing subunit Cox1 as well as subunits Cox4 and 
Cox5a were additionally analyzed. Interestingly, the steady-state 
concentration of the latter two proteins proved to be unchanged, whereas the 
concentration of Cox1 was reduced from 24 h to 72 h post transfection. 
Thereafter the signal intensity gradually rose until the end of the experiment 
(144 h) and reached levels of control cells (Figure 3.4).  
 
3.2.5 SUBDIFFRACTION-RESOLUTION FLUORESCENCE IMAGING 
Conventional fluorescence microscopy is limited by the diffraction barrier of 
light and because of this focusing of light always results in a blurred spot, 
whose size determines the resolution (Hofmann et al., 2005). Several recent 
improvements in microscopy techniques resulted in increased resolution and 
contrast to some extent. However, the first technique to really achieve a sub-
diffraction resolution was STED (Stimulated Emission Depletion) microscopy 
(Hell and Wichmann, 1994; Klar et al., 2000; Hell, 2003). Alternative 
methods were developed using stochastic activation of individual fluorophores 
such as stochastic optical reconstruction microscopy (STORM) (Rust et al., 
2006; Huang et al., 2008) or direct dSTORM (Heilemann et al., 2008; van de 
Linde et al., 2008).  
Both STORM and dSTORM are based on the detection of single fluorescent 
molecules and the localization of these molecules with nanometer accuracy 
(Bates et al., 2007; Heilemann et al., 2008). After multiple activation cycles, 
the positions of numerous fluorophores are determined and used to construct 
a high-resolution image. Thereby, organic fluorophores such as Cy5 or 
Alexa 647 in combination with (STORM) (Bates et al., 2005) or without 
(dSTORM) (Heilemann et al., 2005) an activator fluorophore in close proximity 
are used. Especially, dSTORM is compatible with any fluorescence method 
that enables the labeling of target molecules with a reversible photoswitchable 
fluorophore (Heilemann et al., 2005; van de Linde et al., 2008). As 
demonstrated in Figure 3.5 (a) the emission of a fluorophore is read out at 
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647 nm until the fluorophore enters a non-fluorescent dark state. Through 
irradiation with 514 nm, the fluorophore can be switched back to the 
fluorescent state. This transition is reversible and it was demonstrated that 
this occurs with highly reliability up to hundred times per single fluorophore 
(Heilemann et al., 2005).  
 
 
   
(a) A reversible photoswitchable fluorophore conjugated to a biomolecule is reversibly 
switched between a fluorescent and non-fluorescent state upon simultaneous 
illumination with two different wavelengths of light (here 647 and 514 nm). A typical 
fluorescence spot from a single fluorophore (b) can be fitted multiple times to 
Gaussian functions to determine its center of mass, which leads to a localization 
pattern (c). (d) The accuracy of localization, which determines the resolution of the 
method, was determined from over 1,000 single localizations that were overlaid 
yielding a resolution of 20 nm (van de Linde et al., 2008). (e) Fluorescence images of 
Alexa 647 labeled Cox17 were analyzed by dSTORM. The dSTORM image was further 
processed with a spot-finding algorithm, and individual locations of labeled molecules 
above a threshold are expressed as red spots. 
 
In (b) a typical fluorescence spot from a single fluorophore can be seen, 
which can be fitted multiple times to Gaussian functions to determine its 
center of mass for each fluorophore. The localization of individual molecules in 
Figure 3.5. The principle of dSTORM image analysis.
(c) 
(b) 
Alexa647 labeled Cox17 
(a) (d) 
(e) 
 
dSTORM 
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separate switching cycles can be summed up and used to determine the 
accuracy of localization (Figure 3.5 (c)). 
 
High-resolution images were applied to analyze the effect of Cox17 depletion 
of the protein distribution of Cox17 and COX in collaboration with Prof. Dr. 
Markus Sauer (Applied Laser Physics and Laser Spectroscopy, Universität 
Bielefeld). For this purpose, COX17 transfected HeLa cells were plated in eight 
well chambered coverglass (Lab-Tex™, Nunc) and fixed using 3.7 % 
paraformaldehyde in PBS. In order to stain Cox17 or COX, cells were 
incubated either with polyclonal anti-Cox17 or with monoclonal anti-
complex IV subunit Cox1 antibodies and subsequently with Alexa 647 labeled 
secondary antibody. The fluorescence spots emitted from single Alexa 647 
labeled F’ab-fragments during each fluorescence cycle were identified in each 
image applying an intensity threshold and were fitted to a Gaussian function 
to determine the center of mass for each fluorophore (see Figure 3.4 (e)).  
 
Immunofluorescence images and high-resolution dSTORM images of 
mitochondria with immunolabeled COX subunit Cox1 and Cox17 are shown in 
Figure 3.6 (a) and (b), respectively.  
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(a) Fluorescence images of a section of pTurboRFP-mito HeLa cells (left), 24 h, 72 h 
and 120 h after transfection with COX17 siRNA 2, immunolabeled with Alexa Fluor 647 
anti-complex IV subunit Cox1 (middle). The resolution of the immunofluorescence 
image is substantially improved applying dSTORM (right). (b) Fluorescence images of a 
section of pTurboRFP-mito HeLa cells (left), 24 h, 72 h and 120 h after transfection 
with COX17 siRNA 2, immunolabeled with Alexa Fluor 647 anti-Cox17 (middle). The 
reconstructed dSTORM images reveal structural details on the distribution of Cox17 
upon COX17 knockdown (right). A magnified view of the fluorescence images and 
dSTORM image (yellow frame) is shown for the control cells.  
Figure 3.6. Subdiffraction-resolution imaging of immunolabeled pTurboRFP-
mito HeLa cells transfected with COX17 siRNAs.  
(b) 
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Typical immunofluorescence images of mt structure were generated by 
objective type total internal reflection fluorescence microscopy and are shown 
in Figure 3.6 (a) left (pTurboRFP-mito) and middle (CIV-subunit Cox1 / 
Alexa 647) and (b) middle (Cox17 / Alexa 647). dSTORM was applied to 
generate high-resolution images of individual COX or Cox17 localizations ((a) 
and (b), respectively, right). The high-resolution images were constructed 
from a series of ~8,000 individual localizations of individual single F’ab-
fragments.  
Clearly, a much finer structure is observed in the magnified view of the 
reconstructed images, compared to the fluorescence images (yellow frame), 
which demonstrate the strength of the dSTORM method in improvement of 
the resolution. In contrast to the conventional fluorescence images, the 
dSTORM images showed clearly separated clusters of localization, whereby 
each cluster corresponds to an individual protein molecule and resulting from 
repetitive localizations of a single Alexa 647 molecule over multiple switching 
cycles.  
Similarly to the results obtained for the COX17 knockdown on the mRNA and 
protein level, Cox17 localizations are markedly diminished 72 h post 
transfection (Figure 3.6 (b)). Thereafter, the Cox17 localizations gradually 
increase until the end of the experiment (120 h), reaching approximately 
50 % of control levels. In contrast, the distribution of COX subunit Cox1 did 
not vary over the time of the experiment. This was unexpected, as steady-
state levels of Cox1 became strongly reduced, reaching its minimal level at 
72 h (Figure 3.4). However, in their native state, local clustering of a certain 
number of COX molecules (oligomerization) and the formation of COX-
containing supercomplexes may lead to inaccessible antibody binding sites in 
immunocytochemistry. In contrast, Cox1 steady-state concentration has been 
accessed under denaturing and reducing conditions on SDS-PAGE. 
 
3.3 PHENOTYPICAL CHARACTERIZATION  
To describe the phenotype of COX17 knockdown cells different parameters 
were analyzed. Multi-parameter phenotypical profiling included (i) growth of 
cells on DMEM without glucose supplemented with 10 mM galactose, (ii) cell 
cycle analysis by propidium iodide (PI) staining, (iii) apoptosis assay by 
Annexin V-FITC / PI staining, (iv) ROS analysis with DCFH-DA and (v) 
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determination of oxygen consumption. Each of these methods can measure 
changes in several cellular processes in order to systematically evaluate the 
effect of COX17 silencing. 
 
3.3.1 GROWTH ANALYIS  
To address the question whether COX17 knockdown affects growth of 
transfected HeLa cells, cell titers of vital HeLa cells transfected with negative 
control siRNA or COX17 siRNA 2 were compared with that of untransfected 
cells. As shown in Figure 3.7, knockdown of COX17 leads to a substantial 
reduction of the cell titer, indicating the importance of this copper chaperone 
for growth of the HeLa cells. 
 
  
Cell titers of untransfected HeLa cells (WT, ♦), and of cells transfected with negative 
control siRNA (▲) or COX17 siRNA 2 (•) were determined at the indicated time points 
after transfection (mean values of five measurements and minimum and maximum are 
given with error bars). 
 
3.3.2 CELL CYCLE ANALYSIS  
PI staining was used in order to identify phenotypic changes in the cell cycle. 
For this purpose, transfected and untransfected HeLa cells were permeabilized 
Figure 3.7. Growth of COX17 knockdown cells.
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and incubated with PI. PI intercalates into cellular DNA and the fluorescent 
signal, which is directly proportional to the DNA content, can be analyzed by 
flow cytometry. Figure 3.8 (upper left), shows a typical distribution with the 
majority of cells in the G0/G1 phase (tallest peak). The small rightmost peak 
in the histogram shows the cells in the G2/M state, and the area between 
these peaks refers to cells within the S-phase. The following two histograms 
show the cell cycle state of negative control siRNA transfected cells 72 h and 
144 h post transfection. The lower panels visualize cell cycle analysis of cells 
transfected with COX17 siRNA 2 24 h, 72 h and 144 h post transfection. A 
time-course study (24 h – 144 h) monitoring changes of the cell cycle can be 
seen in Appendix, Figure 5.1. PI data were quantified using the peak fitting 
program of the Partec FloMax® FCM Data Acquisition and Analysis Software 
(materials and methods, Figure 2.2). The results are visualized in the circular 
chart inside each histrogram.  
 
 
  
HeLa cells transfected with negative control siRNA or COX17 siRNA 2 were analyzed 
with PI staining followed by flow cytometry. PI data were automatically modeled with 
the peak fitting program of the Partec FloMax® FCM Data Acquisition and Analysis 
Software. Circular chart: proportions of cells in each cell cycle phase. Data acquisition 
was conducted by collecting 20,000 cells per sample.  
Figure 3.8. Cell cycle analysis.
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Cell cycle analysis indicates that knockdown of COX17 resulted in a distinct 
increase of cells in the sub-G1 phase (dead cells/cell debris), accompanied by 
a decrease in cells at G1 phase. The amount of cells in the sub-G1 phase 
gradually rose in the course of the experiment: while 24 h after transfection 
about ~5 % of cells were within the sub-G1 peak, an increase towards the 
sub-G1 phase could be observed after 72 h and 144 h with respective ratios 
of 14 % and 22 %. In contrast, the percentage of cells in S, G2 and mitosis is 
relatively uniform and unaffected by COX17 knockdown. These experiments 
indicated that downregulation of COX17 triggers apoptosis in HeLa cells.  
 
3.3.3 APOPTOSIS ASSAY 
To further verify that the cells showing an enrichment of sub-G1 indeed were 
undergoing apoptosis, COX17 siRNA and negative control siRNA treated cells 
were stained with Annexin V-FITC and PI (Figure 3.9).  
The measurement of Annexin V-FITC binding to the cell surface was 
performed in conjunction with the vital dye PI to distinguish between non-
apoptotic (Annexin V-FITC negative / PI negative), early apoptotic (Annexin 
V-FITC positive / PI negative) and late apoptotic or necrotic cells (Annexin V-
FITC positive / PI positive) (materials and methods, Figure 2.3) in one 
sample.  
Therefor, the same cell cultures used for the cell cycle analysis were analyzed 
by flow cytometry using the FL1 and FL2 channels for detection of Annexin V-
FITC and PI staining, respectively.  
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HeLa cells were transfected with COX17 siRNA 2 or negative siRNA for the indicated 
times. After detachment with trypsin, the cells were stained with CytoGLO™ Annexin 
V-FITC Apoptosis Detection Kit. The cell populations in the lower left quadrants 
represent non-apoptotic cells, in the lower right quadrants early apoptotic cells and in 
the upper right quadrants late apoptotic or necrotic cells. A total of 20,000 cells were 
counted for each sample. Additional time points (48 h, 96 h and 120 h) are 
summarized in Appendix, Figure 5.2. 
 
Regular flow cytometric cell cycle analysis revealed a slight increase in the 
sub-G1 peak for COX17 knockdown cells, indicating apoptosis at 72 h post 
transfection. As analyzed by light microscopy, the COX17 transfected cells 
displayed significant apoptosis compared to control cells starting at 72 h post-
transfection (data not shown). Figure 3.9 shows the representative results of 
three experiments to determine the kinetics of cell death caused by COX17 
knockdown in HeLa cells by Annexin V-FITC / PI staining.  
Therein an increase of early-apoptotic cells over the time with a maximum at 
the end of the experiment is shown (52 % apoptotic cells at 144 h post 
transfection). The results are consistent with the observed cell proliferation 
rate and cell cycle analysis and suggest that COX17 knockdown cells are less 
viable due to an increase in apoptosis. 
Figure 3.9. Identification of apoptotic cells by flow cytometry.
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3.3.4 DETECTION OF ROS  
ROS are reactive molecules that are formed as by-products of normal 
metabolism of aerobic organisms and have the potential to cause cellular 
damage. COX is higly efficient at reducing oxygen to water, and it releases 
very few partly reduced intermediates. However, during respiration a small 
amount of electrons leaks from the electron carriers and passes directly onto 
oxygen, giving the superoxide radical,·O2•−, best documented for Complex I 
and Complex III (Turrens, 2003). The term ROS is used for short-lived 
diffusible entities such as hydroxyl (•OH), alkoxyl (RO•) or peroxyl (ROO•) 
radicals and for some radical species of medium lifetime such as superoxide 
(O2•−) or nitroxyl radical (NO•). It also includes the non-radicals hydrogen 
peroxide (H2O2), organic hydroperoxides (ROOH) and hypochlorous acid 
(HOCl) (Simon et al., 2000). Cells are usually able to defend themselves 
against ROS through a variety of antioxidant defences and repair enzymes 
(e.g., reduced glutathione, catalase, and superoxide dismutase). However, if 
generated in excess, ROS can mediate cellular oxidative stress often leading 
to programmed cell death. 
To investigate the involvement of ROS in the regulation of apoptosis in COX17 
knockdown cells, the extent of cellular ROS was assayed using DCFH-DA. 
Briefly, non-fluorescent DCFH-DA is taken up by cells, and once inside the 
cell, the diacetate residues are cleaved by intracellular esterases, liberating 
DCFH (Gomes et al., 2005). DCFH reacts predominantly with highly oxidizing 
species of ROS such as hydroxyl radicals and peroxynitrite. Highly fluorescent 
DCF is formed, which can be analyzed by flow cytometry.  
 
In order to confirm the principal function of the assay, HeLa cells treated with 
paraquat (a known generator of intracellular ROS) were analyzed by flow 
cytometry using the FL1 channel (materials and methods, Figure 2.4). 
Although a defined mechanism underlying paraquat toxicity has not been 
described yet, it is widely acknowledged that a cyclic single-electron 
reduction/oxidation is a critical mechanistic event (Bus and Gibson, 1984). 
Paraquat radicals are formed as a consequence and donate their electrons to 
molecular O2, producing O2•− radicals, which are supposed to be the primary 
mediator of the biological toxicity of paraquat (Krall et al., 1988). 
 
                                                                                                       
                                                                                                       RESULTS 
 
 62 
 
  
HeLa cells were transfected with negative control siRNA or COX17 siRNA 2 and 
harvested at the indicated time points. The cells were washed with PBS and incubated 
for 15 min with 50 µM DCFH-DA in ethanolabs at 37 °C in the dark. Cellular ROS 
induction was analyzed by flow cytometry using the FL1 channel. A total of 10,000 
cells were counted for each sample. 
 
As shown in Figure 3.10, COX17 knockdown induced a time-dependent 
increase in cellular ROS levels as defined by DCF fluorescence (RN2). While 
untreated and negative control siRNA transfected cells show no fluorescence 
of RN2 (upper panels), COX17 knockdown cells produce high fluorescence of 
RN2 at 72 h post transfection, indicating increased ROS production (lower 
middle panel). Remarkably, 144 h after COX17 transfection a strong shift 
toward the RN2 peak could be observed. The generation of ROS upon COX17 
silencing might be one important trigger mechanism responsible for the 
observed increase in apoptotic cells. This is in line with the growing evidence 
that ROS are important for the induction of apoptosis due to the disruption of 
the mt membrane potential (Zamzami et al., 1995).  
 
Figure 3.10. ROS production in HeLa cells.
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3.3.5 OXYGEN MEASUREMENT 
To have a closer look on the effect of COX17-targeting RNAi on the 
functioning of mt OXPHOS, cell culture oxygen consumption rates of 
untreated, control and COX17 siRNA transfected HeLa cells were determined. 
For this purpose HeLa cells were seeded in 24 well OxoDish®plates, containing 
a polymeric oxygen sensor at the bottom of each well. The 24 well plates 
were placed on a SensorDish® reader (PreSens Precision Sensing) and 
dissolved O2 was measured online without removing or damaging cells during 
cultivation.  
Readings were taken in 60 min intervals. Figure 3.11 represents the results 
obtained for oxygen measurement of untreated, COX17 siRNA 2 and negative 
control siRNA transfected cells, 24 – 144 h after transfection in relation to the 
number of living cells.  
 
 
 
Rate of dissolved O2 was measured by optical-chemical sensor for untreated (WT,♦), 
negative siRNA (▲) and COX17 siRNA 2 (•) transfected cells. Oxygen consumption per 
cell number was calculated for the indicated time points. (Mean values of three 
measurements and minimum and maximum are given in error bars). 
 
The results show a significantly lower rate of oxygen consumption in cells with 
decreased levels of Cox17, compared to untransfected and negative siRNA 
transfected cells. In the presence of 1 mM cyanide, an effective inhibitor of 
COX, oxygen uptake was almost completely inhibited, demonstrating that the 
Figure 3.11. Respiration rate in COX17 knockdown cells.
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observed oxygen consumption can be attributed to the mt respiratory chain 
(data not shown). Maintenance of cellular activities of COX17 knockdown cells 
at diminished O2 consumption may explain their reduced growth rate. 
 
3.4 CYTOCHROME C OXIDASE ACTIVITY  
Yeast cells harboring a COX17 null mutant fail to grow on non-fermentable 
carbon sources and are respiratory deficient. In general, the rate of growth of 
a strain on a non-fermentable medium reflects its COX activity (Punter and 
Glerum, 2003). To determine whether the growth rate of the COX17 siRNA 
transfected HeLa cells correlates with the enzymatic activity of COX, 
mitochondria of untreated cells, COX17 and negative control siRNA 
transfected HeLa cells were isolated and the COX activity was measured 
photometrically. This assay is based on the decrease in absorbance at 550 nm 
of reduced cytochrome c upon its oxidation by COX. 
 
 
Enzymatic activity of COX in mitochondria of cells treated with siRNA against COX17 
was normalized to the activity of citrate synthase and related to the activity to cells 
transfected with negative control siRNA (100 %) (Mean values of three measurements 
and minimum and maximum are given in error bars). 
 
Figure 3.12. COX activity of COX17 knockdown cells.
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COX activity of negative control was set to 100 %. As can be seen in 
Figure 3.12, COX activity gradually declined to ~60 % within the first 72 h 
after transfection and then remained almost constant up to 144 h. The 
observed decline in COX activity is in line with the half life of COX of about 
three days (Stiburek et al., 2006), which was determined by activity 
measurement upon treatment of cells with cyanide. 
 
3.5 CHARACTERIZATION OF MT OXPHOS COMPLEXES 
The Blue native (BN)-PAGE is a useful tool for isolating intact membrane-
associated protein complexes and for investigating the molecular organization 
of mt respiratory complexes (Schägger, 1995). The OXPHOS complexes retain 
enzyme activity upon separation by BN-PAGE (Schägger and von Jagow, 
1991), whereby the protein complexes as well as the assembled 
supercomplexes can be easily detected by in gel activity staining. A major 
advantage of the method is that the activity of different organized forms of 
the complexes are readily ascertained and that non-specific activities do not 
interfere, because they are unlikely to have the same size and mobility as the 
complex of interest (Nijtmans et al., 2002).  
 
To address the question whether depletion of Cox17 affects activity of RC 
complexes and their supramolecular organization, mt protein complexes were 
analyzed by BN-PAGE and subsequently detected either by their enzymatic 
activity (first dimension), or with antibodies after separation in a SDS-gel 
(second dimension).  
 
3.5.1 BN-PAGE/IN GEL ACTIVITY ASSAYS  
Native separation of mt membrane complexes of untransfected HeLa cells, 
negative siRNA and COX17 siRNA 2 transfected HeLa cells was performed to 
monitor changes of the OXPHOS complexes during COX17 knockdown. In gel 
activity staining was used to define the activity of NADH dehydrogenase, 
cytochrome c oxidase and lactate dehydrogenase (LDH).  
Mitochondria isolated from transfected or untransfected HeLa cells were 
solubilized by the non-ionic detergent digitonin and loaded on a non-
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denaturing BN-gel. Apparent molecular masses were determined by using 
molecular mass markers. Figure 3.13 shows the result of the complex I, 
complex IV and LDH in gel activity assays.  
In gel activity staining of complex I (by NADH dehydrogenase activity) was 
displayed by purple bands at a MW above 1 MDa resulting from formazan 
precipitation (1*) (Grandier-Vazeille and Guerin, 1996; Krause et al., 2004). 
In untransfected cells and control samples faint bands with approximately the 
same distance to each other indicate the formation of the known 
supercomplexes I1III2IV0-4 (Schägger and Pfeiffer, 2000). Complex IV activity 
(2*) was determined by the cytochrome c dependent oxidation of 
diaminobenzidine to brown oxide and indamine precipitates (Guerin et al., 
1979; Wittig and Schägger, 2007). COX activity was detected at 
approximately 440 kDa, which represents the complex IV dimer (Krause et 
al., 2005). With cytochrome c as substrate, active bands were not obtained 
for mitochondria treated with COX17 siRNA for 72 h. 
 
 
Mt membrane proteins (200 µg) of untransfected HeLa cells (WT) and of HeLa cells 
transfected with either negative siRNA (control) or COX17 siRNA 2 (48 h and 72 h post 
transfection) were solubilized by digitonin (detergent:protein ration of 4:1) for 15 min. 
OXPHOS complexes were separated by BN-PAGE (3 %-13 %) and subsequently 
subjected to NADH dehydrogenase (1*), COX (2*) and LDH (3*) in gel activity 
staining. 
Figure 3.13. BN-PAGE/in gel activity of digitonin solubilized mitochondria. 
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Interestingly, activity staining of LDH (Figure 3.13 (3*)) revealed an increase 
in LDH activity 72 h after transfection. In gel activity assay was adapted 
following the instruction described for the pyruvate dehydrogenase (PDH) 
(Gey et al., 2008), using lactic acid as substrate instead of pyruvate. LDH 
activity was detected at approximately 120–160 kDa, representing different 
isoenzymes. In most tissues LDH is composed of five isoenzymes with a 
molecular weight of ~140 kDa, as estimated by gel-filtration chromatography 
(Massaro, 1970). The increase of the LDH activity could indicate that the 
knockdown of COX17 leads to an impaired RC activity and a concomitant 
increase in anaerobic glycolysis, which results in elevated lactate production.  
 
However, the most interesting information is the time course of supercomplex 
changes, as visualized by NADH dehydrogenase activity (1*). In order to 
follow the time-dependent changes in supercomplex formation, one focus of 
this thesis was to optimize the in gel activity assays to facilitate comparative 
analysis of the specific activities of supercomplexes; this was done using 
bovine heart mitochondria (BHM).  
 
3.5.2 SUPRAMOLECULAR ORGANIZATION OF COX  
BN-PAGE/in gel activity assays were used to confirm the functional integrity of 
supercomplex components by using digitonin as solubilizing detergent. 
Therefore, NADH dehydrogenase activity of complex I and cytochrome c 
oxidase activity of complex IV, respectively, were visualized by in gel activity 
staining. Only the results of the complex I activity staining are shown in 
Figure 3.14. Staining of supercomplexes for complex IV activity was too faint 
to be visualized in photographs. The various bands were assigned according 
to characterized supercomplexes (Schägger and Pfeiffer, 2000). In gel activity 
staining of complex I of BHM, untreated and control HeLa cells revealed the 
typical pattern of supercomplexes with four major bands that represent 
different assemblies of complexes I, III and IV as described by Schägger & 
Pfeiffer (2000). Based on the nomenclature of these authors, supercomplexes 
of HeLa cells were assigned in the molecular mass range between 1.5 and 
2.1 MDa as supercomplexes SC a–d (SC a: I1III2; SC b: I1III2IV1; SC c: 
I1III2IV2; SC d: I1III2IV3, with SC b at ~1.7 MDa being the major physiological 
module of the mammalian RC (Schägger and Pfeiffer, 2001).  
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48 h, and more pronounced 72 h after transfection of COX17 siRNA, SC d and 
SC c+d, respectively, are no longer detectable, while the abundance of SC b 
and SC a seems to be constant or even slightly increase.  
 
 
  
Mt proteins of bovine heart (BHM), untransfected HeLa cells (WT) and of HeLa cells 
transfected with either negative siRNA (control) or COX17 siRNA 2 (48 h and 72 h post 
transfection) were isolated and solubilized with digitonin. In gel NADH dehydrogenase 
activity was determined after BN-PAGE. Supercomplex composition, MW and 
nomenclature were assigned according to Schägger and Pfeiffer (2000).  
 
3.5.3 MOLECULAR ORGANIZATION OF COX17  
Two dimensional gelelectrophoresis (2D-BN/SDS-PAGE) was used to study the 
molecular organization of Cox17. Therefore, mitochondria of COX17 siRNA 
and negative control siRNA transfected HeLa cells were subjected to BN-PAGE 
with an additional second dimension under denaturing conditions. For this 
purpose, the gel strips from the first dimension were incubated in SDS and 
TCEP and assembled on a SDS-PAA gel followed by Western blot analysis 
(materials and methods, chapter 2.2.9.2 and 2.2.10). The native complexes 
dissociate into their subunits and can be detected immunologically. The 
resulting patterns of proteins detected in the digitonin solubilized 
mitochondria are shown in Figure 3.15 (a) + (b)). As expected the strong 
signals observed in control HeLa cells (a) disappeared upon COX17 
knockdown (b), documenting the siRNA specificity.  
Depending on the applied reducing agents, signals resolved in the second 
dimension (SDS-PAGE) differed: under standard conditions (reduction with 
mercaptoethanol or DTT) only a strong diffuse signal of 30-50 kDa [3] was 
visible. In the presence of TCEP additional minor bands of 10-15 kDa [1] and 
25-30 kDa [2] were detected that might correspond to mono- and oligomeric 
forms of Cox17. The various migration forms of Cox17 might be due to 
Figure 3.14. Supramolecular organization of RC complexes.
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inefficient denaturating and reducing conditions during equilibration of the 
first dimension gel strips and eventual reoxidation during electrophoresis of 
the cysteine-rich Cox17 as reported for gel filtration analysis (Voronova et al., 
2007a). With regard to the first dimension (native gel) Cox17 forms [1] and 
[2] and most of form [3] are part of a ~150 kDa complex. Part of form [3] is 
organized in additional complexes.  
 
3.5.4 MOLECULAR ORGANISATION OF COPPER-BEARING COX 
SUBUNITS COX1 AND COX2  
Molecular organisation of OXPHOS complexes in control cells and COX17 
knockdown cells was examined by use of the OXPHOS antibodies mixture 
(Figure 3.15 (a) + (b)). The positions of supercomplexes were assigned as 
supercomplexes a-d as describe above. RC complexes are given as Roman 
numbers (complex I (CI), complex II (CII), complex III (CIII), complex IV 
(CIV) and complex V (CV). 
Complex I seems to be exclusively organized in supercomplexes a-d. 
F1F0 ATPase was mainly present at 750 and 1,300 kDa, possibly reflecting its 
mono- and dimeric form. Complex III was preferentially observed as part of 
the SCs a-d, as well as of two complexes at ~700 and 900 kDa, both co-
migrating with complex IV. According to Schägger and Pfeiffer (2000), the 
latter two could represent supercomplexes III2IV1 and III2IV2, respectively. 
The majority of complex IV was detected at ~440 kDa, most likely 
representing its dimeric form, and as component of SCs b-d. Contrary to the 
results of Acin-Pérez et al. (2008) complex II could not be detected as part of 
SCs. Instead, complex II was exclusively detected at ~150 kDa, 
corresponding to its monomeric form. The OMM protein VDAC that served as 
internal loading control was represented by a number of spots ranging from 
50 to 500 kDa, probably indicating its different supramolecular assemblies 
(Hoogenboom et al., 2007).  
Overall, the gross organization of RC complexes was not affected by COX17 
knockdown. A marked alteration was observed with Cox2 antibody, revealing 
reduced level of SCs, especially of the III2IV2 complex.  
In order to analyze COX organization in more detail, Western blots were 
additionally probed with Cox1 antibody. As indicated in Figure 3.15 ((a) + (b)) 
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Cox17 depletion had a remarkable effect on the organisation of Cox1. In 
addition to the strong reduction of the signals at the position of SC b-d a 
novel complex of ~150 kDa was observed. The comparable sizes of this 
complex and of the above described Cox17-containing complex may hint at 
the simultaneous presence of both proteins.  
 
 
  
(a, b) 2D-BN/SDS-PAGE of RC-complexes of cells transfected with either negative 
siRNA (b) or COX17 siRNA 2 (c) 24 h post transfection. Proteins were blotted and 
probed with antibodies against Cox17 and VDAC, an OXPHOS Human Antibody Cocktail 
(which recognizes the following individual subunits of the indicated OXPHOS 
complexes: ATP synthase subunit alpha (CV), complex III subunit Core 2 (CIII), 
complex II-FeS subunit 30 kDa (CII), complex IV subunit Cox2 (CIV-Cox2) and 
complex I subunit NDUFB8 (CI), and with an antibody against complex IV subunit 
Cox1 (CIV-Cox1). Positions of SCs (a,b,c,d) and RC complexes (Roman numbers) are 
given. Due to the low intensity of the SCs long exposure times were applied, that 
resulted in saturation of the 440 kDa signal. 
 
3.5.5 SUPRAMOLECULAR ORGANIZATION OF RC COMPLEXES 
To study the effect of COX17 knockdown on COX assembly in more detail, a 
time resolved analysis was performed with the total OXPHOS human antibody 
Figure 3.15. 2D-BN/SDS-PAGE of OXPHOS complexes.
(b) (a) 
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cocktail and Cox1 antibody. Since no differences were observed for complexes 
II, III and V and VDAC, only the signals of complex IV (CIV-Cox1 and Cox2) 
and of complex I (CI) are shown in Figure 3.16.  
Complex I signals were detected in the control cells at the positions of SCs   
a-d, with the strongest signal corresponding to SC b. Complex I signals 
associated with SC d disappeared in the course of the experiment and were 
no longer detectable at 120 and 144 h. At these time points, complex I 
signals at the position of SC c are also markedly decreased. These findings 
are in accordance with the results of the complex I in gel activity staining 
(Figure 3.14), and confirm the effect of COX17 knockdown on the 
supramolecular organization of RC.  
Detection with COX-specific antibodies likewise revealed alterations in the SC 
organisation. Starting from 24 h after transfection of siRNA until the end of 
the experiment (144 h), the Cox1, but not the Cox2 antibody detected the 
above described 150 kDa complex. Concomitantly, substantial decreases of 
Cox1 and Cox2 signals in SC b-d were noticed. Already at 24 h both COX 
subunits are no longer visible in the area of SC d. After additional 48 h, they 
are also not detectable at the positions of SC b and c. 
The Cox1 and Cox2 signals in III2IV1 and III2IV2, respectively, progressively 
decreased up to 96 h post transfection. Interestingly, weak signals 
reappeared after 120 h, indicating the formation of new complexes. In 
contrast, the steady-state concentrations of Cox1 and Cox2 in the COX dimer 
of 440 kDa seems to be unaffected by COX17 knockdown.  
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Time course of the molecular organization of complex IV (CIV) and complex I (CI) in 
COX17 siRNA 2 transfected cells. Proteins were separated by 2D-BN/SDS-PAGE, blotted 
and probed with antibodies against Cox1 (CIV-Cox1), Cox2 (CIV-Cox2) and NDUFB8 
subunit of complex I (CI). Positions of SCs (a,b,c,d) and RC complexes (Roman 
numbers) are given. Due to the low intensity of the SCs long exposure times were 
applied, that resulted in saturation of the 440 and 150 kDa signals. 
 
3.5.6 DSTORM OF SUPERCOMPLEXES  
Supercomplexes are described as the most efficient form of the RC to 
generate energy, and advantages of such multienzyme complexes over 
individual activities has been proposed: substrate channelling, catalytic 
Figure 3.16. Molecular organization of RC complexes.
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enhancement, and sequestration of reactive intermediates (Bianchi et al., 
2004; Schägger et al., 2004). Calculated 3D maps of I1III2IV1 were already 
generated upon electron microscopy analysis and gave first insights into the 
positions and interactions of the individual RC when assembled into SCs 
(Schäfer et al., 2007).  
 
To non-invasively image intracellular SC formation in HeLa cells, 
subdiffraction-resolution fluorescence images were taken.  
 
 
 
Total internal reflection fluorescence images of pTurboRFP-mito HeLa cells (upper left) 
with a magnified view of a mt structure (upper right). HeLa cells were transfected with 
COX17 siRNA 2 72 h and immunolabeled with Alexa Fluor 647 anti - MitoProfile® Total 
OXPHOS Human WB Antibody Cocktail. The reconstructed dSTORM image (lower left) 
reveals structural details on the distribution of supercomplexes in the IMM (lower 
right). 
 
To perform dSTORM imaging of SCs in the IMM, immunocytochemistry was 
used. In Figure 3.17 (upper left), a typical immunofluorescence image of 
pTurboRFP transfected HeLa cells is shown. The cells were incubated with the 
Figure 3.17. dSTORM of supercomplexes.
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total OXPHOS human antibody cocktail that comprises antibodies against 
subunits of all OXPHOS complexes, and dSTORM was applied (lower left). The 
magnified view exhibits an obviously higher resolution of the protein 
distribution along the IMM. Thus, dSTORM may represent a novel method to 
provide structural information of SCs. 
 
Differences between control and COX17 siRNA transfected HeLa cells were not 
observed. One reason for this may be that epitopes recognized by the 
different antibodies may be hidden due to the SC formation.  
 
3.6 COPPER SUPPLEMENTATION 
Growth of S. cerevisiae COX17 mutant on non-fermentable substrates could 
be restored by addition of copper. To test, whether increased copper 
concentrations could also rescue the COX17 phenotype in HeLa cells, COX17 
knockdown cells were incubated with copper histidine (Cu–His). Cu-His 
presents copper in a physiologically suitable form, as it is suggested that 
copper uptake by hepatocytes and brain tissue is mediated by histidine 
(Barnea et al., 1990; Katz and Barnea, 1990; Harris, 1991). Clinical benefit of 
Cu-His therapy has been documented in several patients with Menkes disease 
(Kreuder et al., 1993; Sarkar et al., 1993). 
Different concentrations of Cu-His were added either one day before 
transfection or 24 h or 72 h after transfection with COX17 siRNAs. The cells 
were incubated for at least another 24 h up to 144 h after transfection. COX 
activity of isolated mitochondria was determined spectrophotometrically and 
steady-state levels of COX subunits Cox1 and Cox2 were analyzed by Western 
blot. No differences were observed between COX17 siRNA transfected cells 
incubated with or without Cu-His (data not shown). The applied 
concentrations of added copper were not able to rescue COX17 deficiency in 
HeLa cells. At higher concentrations of Cu–His increased cell death was 
observed in both, untreated and COX17 siRNA-treated cells, probably 
reflecting copper toxicity.  
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4 DISCUSSION 
Assembly of COX, the terminal enzyme of the eukaryotic RC, involves the 
interplay of two different genomes and requires the assistance of a number of 
assembly factors acting at several levels of the process. The function of COX 
is crucial for the regulation of ATP production within mitochondria and has a 
major impact in human health (Barrientos et al., 2002). 
The knowledge of delivery and insertion of copper into COX during 
holoenzyme biogenesis is still limited, although an extensive set of data 
describing structural and functional features of this complicated process is 
available. So far, a total of eight soluble (Cox17, Cox19, Cox23, Pet191, 
Cmc1-4) and three integral membrane (Cox11, Sco1, Sco2) proteins with 
essential roles in copper delivery to COX have been identified in yeast, all of 
them having human orthologues (Leary, 2010). These proteins are either 
exclusively localized in mitochondria or possess a dual localization in the 
cytoplasm and mt IMS. Moreover, depletion of most of them results in 
respiratory deficiency and often in disassembly of COX subunits 
(Khalimonchuk and Rödel, 2005), indicating that the successful delivery of 
metals to the site of COX assembly and their proper insertion are important 
steps in the complex formation. 
 
This thesis focuses on human Cox17 and provides a systematic examination 
of the effect of COX17 knockdown in HeLa cells. Using transient siRNA 
transfection, HeLa cells contain ~90 % reduced COX17 mRNA and protein 
levels. Remarkably, COX17 knockdown cells showed a vastly reduced COX 
activity, an increased level of ROS and apoptotic cells and a markedly 
decreased level of OXPHOS supercomplexes. This raises the question on the 
role of Cox17 in the stability and assembly of the enzyme complexes.  
 
4.1 DUAL LOCALIZATION OF HUMAN COX17 
Involvement of Cox17 in copper homeostasis was originally implicated by the 
observation that the respiratory defect of yeast COX17 null mutants was 
suppressed by high exogenous copper levels (Glerum et al., 1996a). Based on 
its dual localization in the cytoplams and the mt IMS, yeast Cox17 was initially 
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proposed to act as a copper shuttle between these two compartments (Beers 
et al., 1997). In accordance with this proposal, confocal fluorescence 
microscopy of HeLa cells expressing pTurboRFP-mito labeled with Cox17 
antibodies and Western blot analysis of subcellular fractions of HeLa cells 
showed that Cox17 is highly enriched in mitochondria and only a small portion 
(< 20 %) resides in the cytoplasm. In addition, investigations of the 
submitochondrial localization of Cox17 through the formation of mitoplasts by 
hypo-osmotic treatment revealed that Cox17 and the mt IMS marker 
cytochrome c show an identical distribution. These results support the idea on 
Cox17 being a shuttle for copper ions to the mitochondria.  
 
However, in view of the results that tethering of yeast Cox17 to the IMM does 
not cause any respiration defect (Maxfield et al., 2004) and that twin Cx9C 
motif containing mt IMS proteins are imported into the mt IMS by the Mia40 
pathway (Mesecke et al., 2005; Mesecke et al., 2008), this proposal probably 
has to be revised. Hence, the observed distribution possibly reflects the 
equilibrium of the reduced cytosolic form (Cox170S-S) and the oxidized form 
(Cox172S-S) residing in the mt IMS, as described by Voronova et al. (2007b). 
It strongly supports the current hypothesis that the fully reduced Cox17 
protein present in the cytoplasm enters the mt IMS where it is then oxidized 
by Mia40 to Cox172S-S. Partially oxidized Cox172S-S is the functional species in 
the mt IMS, where it is able to bind a single copper ion and enters the 
pathway of copper delivery to COX (Banci et al., 2008b; Sideris et al., 2009). 
Although it is generally suggested that Cox17 donates copper for the 
biogenesis of COX CuA and CuB sites, it is still an open question how copper 
reaches Cox17 in the mt IMS. The existence of a bioactive copper pool within 
the mt matrix is a possible source (Cobine et al., 2006a) and it is proposed 
that a non-proteinaceous copper ligand exports copper to the mt IMS. Copper 
is then chaperoned by Cmc1 or other, yet unidentified metallochaperones to 
Cox17 and subsequently to the COX copper site-specific Sco1/Sco2 and Cox11 
(Arnesano et al., 2005; Leary, 2010). 
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4.2 COX17 KNOCKDOWN AFFECTS STEADY-STATE LEVELS 
OF COPPER-BEARING COX SUBUNITS COX1 AND COX2 
Yeast cells harboring a mutant COX17 gene are respiratory deficient 
associated with COX deficiency (Glerum et al., 1996a). To investigate whether 
mammalian Cox17 has the same impact on respiration, silencing of COX17 in 
HeLa cells was performed using RNAi.  
RNAi is a powerful molecular genetic tool to elucidate gene function, and it is 
an easy-to-use technique, which was initially thought to be highly specific 
(Elbashir et al., 2001). The major disadvantage of RNAi by siRNA is known as 
so-called off-target effects, which are described as unintended protein 
downregulation upon siRNA treatment (Svoboda, 2007). Several data suggest 
that siRNAs specificity is not absolute and off-target gene silencing can occur 
through different mechanisms, including global up/down-regulation of genes 
using high concentrations of siRNA (Persengiev et al., 2004; Semizarov et al., 
2004), the induction of an interferon response (Sledz et al., 2003), micro-
RNA-like inhibition of translation (Doench et al., 2003; Saxena et al., 2003; 
Zeng et al., 2003; Bartel, 2004; Scacheri et al., 2004), and mRNA 
degradation mediated by partial sequence complementation (Jackson et al., 
2003).  
In this thesis several aspects were considered to avoid off-target effects. 
Seven different pre-designed siRNAs targeting human COX17 and two 
scrambled siRNAs which are not complementary to any gene in HeLa cells 
were used to analyze gene specific changes in the expression profiles. Off-
target effects would be seen as siRNA specific rather than gene specific 
changes in gene expression patterns (Dillin, 2003; Jackson et al., 2003; 
Semizarov et al., 2003). The final concentration of siRNA was decreased as 
low as possible due to the usage of highly potent ‘Silencer Select siRNAs’, 
resulting in effective target knockdown at lower concentration than older 
generation siRNAs (www.ambion.com). Off-target effects often occur in 
association with toxic side effects (Fedorov et al., 2006), thus the volume of 
transfection reagent was reduced.  
 
The knockdown of COX17 was verified by qRT-PCR and Western blot analysis. 
COX17 mRNA level was specifically decreased to ~15 % and resulted in 
strongly reduced steady-state levels of Cox17 protein already 24 h post 
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transfection. Depletion of Cox17 was accompanied by a decrease in COX 
activity, which is in accordance with the respiratory deficient phenotype of 
COX17 yeast null mutants (Glerum et al., 1996a). It is likely that the reduced 
COX activity, eventually resulting in a decreased energy supply, explains the 
observed effect of Cox17 depletion on cell proliferation. Reduced growth was 
also observed upon depletion of either COX subunits Cox4 and Cox5a in 
Caenorhabditis elegans (Suthammarak et al., 2009), and upon deletion of the 
COX assembly protein Cox10 in a mouse fibroblast cell line (Diaz et al., 
2006).  
Knockdown of COX17 leds to reduced steady-state levels of the copper-
bearing subunits Cox1 and Cox2, but not of subunits Cox4 and Cox5a. 
A temporal decrease of the mt encoded subunits of COX was already observed 
in SCO1 patients due to a defective Cox17 mediated copper metallation of 
Sco1 (Paret et al., 2000; Cobine et al., 2006b). The authors suggest that an 
inefficient maturation of the CuA site is the basis for the inefficient assembly of 
the COX complex and results in rapid degradation of unassembled subunits in 
the matrix. This is supported by the finding that mitochondria contain an 
evolutionary conserved ATP-dependent protease system in the IMM, which 
rapidly degrades mt proteins that are not incorporated into nascent enzyme 
complexes (Arnold and Langer, 2002; Williams et al., 2004). Within this 
context, it seemed that the COX17 knockdown had a much stronger impact on 
Cox2 than on Cox1. Similar differences in the stability of the two COX 
subunits have been observed in pulse-chase experiments of yeast cells lacking 
the COX assembly factor Sco1 (Schulze and Rödel, 1989; Krummeck and 
Rödel, 1990). As outlined by Rossmanith et al. (2008), co-translational 
incorporation of mt encoded subunits into pre-existing subcomplexes may 
account for their stability. The higher stability of Cox1 compared to Cox2 may 
result from the sequential COX assembly, with the first assembly intermediate 
containing Cox1, Cox4 and Cox5a (Fernandez-Vizarra et al., 2009). 
Subunits of RC complexes II, III and V were not affected, whereas steady-
state concentration of complex I subunit NDUFB8 was slightly reduced. This 
effect may be attributed to a secondary destabilization of complex I by COX 
defects, as previously reported (D'Aurelio et al., 2006; Li et al., 2007). Loss of 
COX in knockout mice lacking COX subunit 10, which is involved in heme a 
synthesis, also resulted in the loss of complex I (Diaz et al., 2006). This 
supports the prevailing hypothesis, that presence of COX in substantial 
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amounts is needed for the formation of respirasomes (Schäfer et al., 2006; 
Vonck and Schäfer, 2009).  
 
Subdiffraction-resolution fluorescence imaging (dSTORM) was applied to 
analyze the effect of Cox17 depletion of the protein distribution of Cox17 and 
COX. dSTORM images provided clearly separated individual protein molecules, 
which in case of Cox17 substantially declined upon COX17 siRNA transfection, 
confirming the results obtained by Western blot analysis as well as the 
specificity of the COX17 siRNAs. The localization pattern of COX molecules did 
not vary over the time of the experiment, which can be explained with 
inaccessible antibody binding sites due to local clustering of a certain number 
of COX molecules and the formation of COX containing supercomplexes. 
Within this context, quantification and co-localization studies of Cox17 and 
COX remains an aspect to consider. This should be addressed by dSTORM in 
combination with multi-color high resolution technique, as this offers an 
approach to study protein-protein interaction and protein-aggregation in even 
shorter distances accessible by Fluorescence resonance energy transfer 
(FRET) (Heilemann et al., 2009). Additionally, subdiffraction-resolution 
fluorescence imaging methods might be used for structural analysis of 
supercomplexes.  
 
4.3 SUPRAMOLECULAR ORGANIZATION OF RC IS AFFECTED 
AS AN EARLY RESPONSE TO COX17 KNOCKDOWN 
To investigate the involvement of Cox17 in the biogenesis of OXPHOS in HeLa 
cells, BN-PAGE/in gel activity assays and 2D-BN/SDS-PAGE were performed. 
After applying solubilized mitochondria of COX17 silenced HeLa cells to BN-
PAGE, subsequent in gel activity assay revealed a strong reduction of COX 
activity between 48 h and 72 h post transfection, supporting the photometric 
results. However, oxygen consumption measurement indicates a rather slight 
effect on the respiration capacity. Based on this finding, the suggestion, that 
even low levels of active COX are able to maintain substantial RC function, 
can be made. This is in accordance with the observation of Letellier et al. 
(1993), who have shown that a minimal COX activity can sustain an 
appreciable flux of respiration and that the respiratory rate is not directly 
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proportional to COX activity.  
Interestingly, activity staining of the LDH revealed that reduction in COX 
activity is accompanied by a simultaneous increase in LDH activity 72 h after 
transfection. The role of mt LDHs was already described 1999 by Brooks and 
co-workers and extended by studies of astrocytoma cells (Lemire et al., 
2008). The results confirmed the presence of mt LDH isoenzymes and 
supported the role for mt LDH in tissue lactate oxidation associated with mt 
energy production (Brooks et al., 1999). The increase of the LDH activity in 
the COX17 siRNA transfected cells may maintain the energy supply and could 
indicate an impaired RC activity as well as a concomitant increase in 
anaerobic glycolysis, which results in elevated lactate production. However, 
further studies are needed to confirm these observations. This includes the 
photometrical measurement of the LDH activity with specific inhibitors of the 
mt LDHs (Brooks et al., 1999). Additionally, the lactate concentration in the 
cell culture supernatant should be examined to unveil a possible 
compensatory metabolic effect upon COX17 knockdown.  
Most important, NADH dehydrogenase activity analysis revealed an 
impairment of the supramolecular assemblies of the COX complex upon 
COX17 depletion. COX-containing supercomplexes I1III2IV1-3 disappeared as 
an early response to reduced levels of Cox17. With some delay, the 
concentrations of SC III2IV1 and III2IV2 are also reduced (Figure 3.16). The 
observed effects on SCs were unexpected, as SCs are discussed as the most 
efficient form of the RC to generate energy, due to the enhanced electron 
transfer between complexes and the elevated stability of complexes 
(Schägger and Pfeiffer, 2000; Bianchi et al., 2004; Schägger et al., 2004).  
 
It is widely accepted that exposure of mitochondria to excessive ROS can 
affect the respiratory activity and supercomplex formation of the enzyme 
complexes (Paradies et al., 2002; Zhang et al., 2002; Petrosillo et al., 2003; 
Paradies et al., 2004; Lenaz and Genova, 2007). The mt RC constitutes the 
main intracellular source of ROS in most tissues and a variety of antioxidant 
defenses and repair enzymes maintains the steady-state levels of these 
oxidants at non-toxic levels (Boveris, 1977; St-Pierre et al., 2002; Starkov et 
al., 2004). An imbalance between defense and ROS production by either 
deficient antioxidant defenses, inhibition of electron flow or exposure to 
xenobiotics may mediate cellular oxidative stress, often leading to apoptosis 
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and cell death (Green and Reed, 1998; Kowaltowski et al., 2001; Kim et al., 
2003; Turrens, 2003). Moreover, evidences are accumulating that 
supercomplexes are altered with age, and in some pathological cases, related 
to oxidative stress (Dencher et al., 2007). That indicates that the assemblies 
of RC supercomplexes might be modulated by an age- or disease-dependent 
increase in membrane viscosity caused by ROS stimulated lipid peroxidation. 
In consistency with these data, disassembly of SCs was accompanied by 
increased ROS levels and a considerable induction of apoptotic cells upon 
COX17 knockdown. The central idea is that depletion of COX17 results in an 
overall cellular imbalance associated with cumulative cellular stress due to an 
inefficient transport of copper. As free copper has the potential to generate 
ROS via Fenton reaction (Spasojevic et al., 2010), it is likely that an impaired 
copper delivery either from cytosol to mitochondria or within mitochondria 
leads to a disassembly of COX-containing SCs and initiation of the apoptotic 
pathway by increasing the permeability of the OMM (Liu et al., 1996; Li et al., 
1997).  
As an alternative scenario, depletion of Cox17 may primarily lead to an 
impairment of the SC formation and subsequently to the induction of ROS. 
SCs are thought to increase the electron transfer rate to minimize the leakage 
of electrons that can potentially generate ROS (Panov et al., 2007; Vonck and 
Schäfer, 2009). Studies on superoxide generation by complex I suggest that 
loss of supercomplex organization induces excessive ROS formation (Dencher 
et al., 2007; Lenaz and Genova, 2007), although no specific study has been 
yet addressed this question. Complex I and III are considered as significant 
sources of ROS (Turrens, 1997; Liu et al., 2002; Genova et al., 2003), and in 
isolated complex I, flavin mononucleotide (FMN) is proposed to be the major 
electron donor to oxygen to form superoxide anion (Esterhazy et al., 2008). 
FMN only becomes exposed to oxygen when complex I is dissociated from 
complex III (Lenaz et al., 2010).  
In this context, the effect of the COX17 knockdown mediated induction of ROS 
of the mt localized SOD (Cu/Zn-SOD or SOD1 and Mn/SOD or SOD2) should 
be taken into account for further experiments. The SOD2 is a key mt 
antioxidant enzyme, which functions in the formation of superoxide into 
hydrogen peroxide and diatomic oxygen (Kokoszka et al., 2001). One would 
assume that the induction of mt ROS is reflected in an increase of SOD2 
expression. Although the role of mt SOD1 in mt function is not known, its 
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localization in the IMS suggests that the enzyme has a functional relationship 
with the occurrence of superoxide in this compartment (Inarrea et al., 2007).  
Induction of apoptosis in COX17 knockdown cells might also indicate an 
indispensable role for Cox17 in cell survival. Homozygous disruption of mouse 
COX17 gene leads to COX deficiency, followed by embryonic death (Takahashi 
et al., 2002). Interestingly, many apoptotic cells were observed in the 
COX17 (-/-) embryo and the authors suggest that Cox17 is essential for COX 
activation and early embryogenesis. The finding of embryonic lethality in 
mouse COX17 mutants may provide an explanation for the lack of obvious 
candidates of human diseases. In contrast, COX deficiency due to mutations 
in several COX assembly factors such as SURF1, SCO1, SCO2, and COX10 are 
associated with a wide range of encephalomyopathic disorders (Shoubridge, 
2001). The unsuccessful attempts to generate a stable COX17 knockdown cell 
line (that will be discussed in more details below) may also attribute to this 
finding.  
 
4.4 COX17 IS PRIMARILY ENGAGED IN COPPER DELIVERY 
TO SCO1/SCO2 
2D-BN-PAGE/SDS-PAGE analysis revealed an impairment of the 
supramolecular assemblies of the COX complex upon Cox17 depletion, while 
the 440 kDa COX dimer seems to be unaffected. Hence, it can be assumed 
that the decrease in COX activity is predominantly caused by this disassembly 
of COX-containing SCs. There is evidence to suggest that the SCs are not 
formed by a simple association of completely assembled RC complexes. In 
that case the COX dimer, whose concentration is unchanged despite the 
COX17 knockdown, could serve as a source to generate novel SCs. Instead SC 
formation is observed only from 120 h on, i.e. after recovery of Cox17, maybe 
depending on newly synthesized COX subunits and/or COX assembly 
intermediates. It is tempting to speculate that the observed 150 kDa complex 
(Figure 3.16) could act as such a precursor form whose maturation requires 
the activity of Cox17. In accordance with such a scenario, Lazarou et al. 
(2009) recently concluded from their data that complex I may associate into 
SCs prior to its completion. 
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What is the exact role of Cox17 in this process?  
Obviously, based on the known role of Cox17 in early steps of COX assembly 
(Horn and Barrientos, 2008), knockdown of COX17 blocks the formation of 
COX and thus the delivery of newly synthesized COX subcomplexes for SC 
assembly. Although it cannot be excluded that Cox17 may play an additional 
role in the SC assembly process, the results obtained in this thesis strongly 
argue in favor of a role of Cox17 in COX assembly before subunit Cox2 is 
inserted. Cox17 depletion results in the accumulation of a subcomplex of 
~150 kDa, which contained Cox1 but not Cox2. Such an intermediate COX 
complex may be identical with the previously described COX assembly core 
denoted as S2 by Nijtmans et al. (1998; 2009). These authors proposed that 
COX biogenesis is initiated by the formation of a pre-assembled subcomplex 
of subunits Cox1, Cox4, and Cox5a. Attachment of heme a, heme a3 and the 
incorporation of copper into subunit Cox1, delivered by Cox11, is a 
prerequisite for the formation of this subcomplex. Subsequently Cox2, loaded 
with copper by Sco1/Sco2, is incorporated.  
Yeast Cox17 is proposed to deliver copper to Cox11 and to Sco1/Sco2 for 
metallation of Cox1 and Cox2, respectively (Glerum et al., 1996b; Horng et 
al., 2004). However, the absence of Cox2 in the 150 kDa subcomplex, but not 
Cox1, suggests an impairment of copper delivery to Cox2 (via Sco1/Sco2), 
but not to Cox1 (via Cox11). Metallation of Cox1 and Cox2 is essential for 
stability, since the absence of the copper centers leads to a rapid degradation 
of the proteins (Horn and Barrientos, 2008). Additionally, copper insertion into 
the membrane-buried CuB center of Cox1 in yeast is proposed to occur 
simultaneously with its translation and folding (Khalimonchuk and Rödel, 
2005).  
Therefore it is appropriate to assume that the Cox1 protein in the ~150 kDa 
subcomplex represents its copper loaded form. The observation that Cox11-
mediated maturation of Cox1 is possible in the absence of Cox17 may indicate 
that Cox11 can recruit copper by different means. By contrast, the 
subsequent incorporation of Cox2, loaded with copper by Sco1/Sco2, seems 
to be interrupted. In accordance with this idea the phenotype of SCO1- and 
SCO2-deficient cells is similar to that of COX17-deficient cells in that fully 
assembled COX is reduced (Leary et al., 2004; Stiburek et al., 2005), 
whereas the Cox1-Cox4-Cox5a containing COX subcomplex (S2) accumulates 
(Williams et al., 2004). This confirms that Cox17 acts upstream of Sco1/Sco2, 
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and may also explain that the 150 kDa complex is lacking Cox2. The specific 
need for metallation of the Sco proteins by Cox17 could also account for the 
observation that the screen for suppressors of a yeast COX17 mutation 
identified only SCO1/SCO2 but not COX11 (Glerum et al., 1996b) as 
multicopy suppressors.  
 
The data argues in favor of Cox17 being primarily engaged in copper delivery 
to Sco1/Sco2 and not to Cox11. Alternatively, Cox17 may be involved in 
copper transfer to both Cox11 and Sco1/2 and possesses a higher affinity for 
Cox11 than for Sco1. In that case the residual Cox17 in the knockdown cells 
may be sufficient for copper delivery to Cox11, but not to Sco1/Sco2.  
In addition to reveal a preferential role of Cox17 for Sco1/Sco2, the studies in 
this thesis point to a so far unknown complexity in the formation of SCs. The 
data indicates that different routes are used for the formation of COX 
complexes organized in SCs and of the COX dimer. It is proposed that a step 
acting downstream of the Cox17-mediated maturation of the ~150 kDa 
complex is decisive for the route towards SCs. 
 
4.5 COPPER SUPPLEMENTATION ALONE CANNOT RESCUE 
THE COX17 PHENOTYPE 
Menkes disease is caused by defects of the evolutionarily conserved copper-
transporting ATPase (Atp7A) (Chelly et al., 1993; Kaler et al., 1994), which is 
required for the copper transport into the trans golgi network for 
incorporation into copper requiring enzymes. So far, very promising results 
were reported in several patients with Menkes disease treated from a very 
early age on with a copper-histidine complex. In addition, respiratory growth 
of yeast COX17 null mutants and COX deficiency of human SCO2 mutant 
myoblasts and fibroblasts could be rescued by the addition of copper to the 
culture medium (Glerum et al., 1996a; Jaksch et al., 2001; Salviati et al., 
2002a).  
To examine whether increased intracellular copper concentrations could also 
rescue the COX deficiency observed in COX17 depleted HeLa cells, copper-
histidine was added in different concentrations and at different timepoints 
(before and after transfection with COX17 siRNAs) to the cell culture medium. 
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In contrast to the data of Jaksch et al. (2001) higher concentrations of Cu–His 
resulted in increased cell death, whereas lower concentrations did not show 
any significant changes in COX activity or cell proliferation. Likewise, the 
decrease of the steady-state concentration of Cox1 and Cox2 remained 
unchanged. Therefore, it is not clear whether the exogenous applied copper 
reaches the CuA and CuB sites. It remains unclear whether the uptake of 
copper into the cell, the transport to/into the mitochondria or the chaperone 
mediated insertion of the cofactor into COX is limited.  
 
4.6 OUTLOOK 
The characterization of COX17 knockdown HeLa cells showed the importance 
of Cox17 in the processes of COX assembly and supercomplex formation.  
 
2D-DIGE protein expression profiling  
To examine the function of Cox17 in these processes in more detail, one way 
would be to analyze the mt proteome upon depletion of COX17. Initial 2D-
DIGE (2D Fluorescence Difference Gel Electrophoresis) and MALDI-TOF/TOF 
(Matrix Assisted Laser Desorption/Ionisation; Time Of Flight) mass 
spectrometer analysis were already performed with the service offered by 
Applied Biomics (Hayward, CA). The ability to directly compare two samples 
on the same gel avoid problems of gel-to-gel variation and made the 2D-DIGE 
the technique of choice for a rapid and accurate analysis of protein differences 
between two samples.  
Thirteen proteins, whose amount was found to be significantly changed after 
COX17 siRNA transfection (Appendix Figure 5.3 (a)) were recovered from the 
gel and subjected to MALDI-TOF analysis after trypsin digestion. These 
proteins were identified with high confidence having ion scores between 67 
and 340 by NCBInr database, but most proteins had no obvious correlation. 
Results revealed that spots 25 and 55 correspond to heat shock protein 60 
(Hsp60) and NADH dehydrogenase subunit NDUFB9, respectively (Appendix, 
Table 1). In the present study, Hsp60, a chaperonin that facilitates 
bidirectional traffic between the mitochondria and the cytoplasm, was down-
regulated and may have an adverse effect on protein folding. Cabiscol et al. 
(2002) showed that Hsp60 deficient cells presented increased ROS levels and 
they proposed that Hsp60 plays a role in protection against both endogenous 
                                                                                                       
                                                                                                  DISCUSSION 
 
 86 
and exogenous oxidative stress. In light of these data, one would have 
expected that Hsp60 is up-regulated following COX17 knockdown mediated 
stress. However, flow analysis revealed, that only a subpopulation of cells 
showed increased ROS. Hence, the observed decrease in Hsp60 levels upon 
COX17 knockdown might reflect the protein level of the heterogeneous 
mixture of cell, in different stages of apoptotis as well as viable cells. 
NDUFB9 was 2.5 fold up-regulated in COX17 siRNA transfected cells compared 
to negative control siRNA transfected cells. The NDUFB9 is a 22 kDa nuclear 
encoded accessory subunit of the mt complex I and its function remains 
unclear. However, as mutations in the gene encoding NDUFB9 may be 
responsible for a specific mitochondrial dysfunction disease, branchio-oto-
renal (BOR) syndrome, it may regulate complex I activity (Lin et al., 1999). In 
line with this, elevated expression of several complex I subunit genes, 
including NDUFB9, was observed in cell lines and tissues from patients with 
various genetically determined OXPHOS defects (Cizkova et al., 2008).  
The majority of the remaining spots were identified as proteins of the 
cytoskeleton and the extracellular matrix. Unexpectedly, proteins which are 
directly or indirectly involved in the metallation or assembly of COX, proteins 
regulating cell growth, differentiation, apoptosis or oxidative stress could not 
be identified (Lee et al., 1999; Limatola et al., 1999; Amills and Bouzat, 
2003; Chalmers et al., 2007). In view of this fact, the defined effect of COX17 
knockdown on the stability of supramolecular organization of RC complexes is 
particularly noteworthy and indicates that short-term COX17 knockdown may 
affect first the molecular organization of complexes rather than their steady-
state levels. However, the stability of the Cox17 affected proteins upon 
transient transfection remains to be considered. Cell sorting to separate 
heterogeneous cells populations prior to proteomic analysis may be taken into 
account for further experiments.  
 
Silencing of COX17 by tetracycline (Tet) inducible short hairpin (sh)-
RNA expression 
In light of the accumulating evidence that Cox17 is essential for the proper 
regulation and assembly of mammalian COX, a stable COX17 silenced HeLa 
cell line would be necessary. This would enable (i) the identification of 
phenotypes upon long term depletion of Cox17, (ii) the access to sufficient 
material for subsequent biochemical assays, and (iii) the analysis of the 
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(suppressive) effect of transient overexpression of other components. To this 
end, the cloning of the necessary expression constructs for Tet-inducible RNAi 
was performed (Appendix 5.4) (Kappel et al., 2007). The transient 
transfection of the inducible RNAi system resulted in the expression of COX17 
shRNAs that efficiently induce gene silencing 72 h post transfection. However, 
the data of COX17 silencing via an integrated doxycycline (dox) inducible 
RNAi cassette appear to be inconsistent and not reproducible. The cultivation 
of several clones was not successful indicating that permanent loss of Cox17 
may be lethal, confirming the reduced growth of the transiently silenced cells. 
The majority of clones showed a reduced growth after incubation with dox. 
The impact of the inducible COX17 shRNA expression was monitored on RNA 
and protein level. Initial results revealed no or only marginal differences 
between the Tet-off and Tet-on state after induction with dox. Most likely, 
differences in the copy number of the integrated shRNA-expression cassette 
and/or the impact of the chromosomal integration sites on expression might 
be responsible for the marginal extent of target suppression.  
 
Knockdown of additional genes 
In terms of better understanding the routing of copper to the mitochondrion 
in mammalian cells, knockdown of additional individual genes (CMC1; COX19; 
COX23) and combinations of genes (COX17 + CMC1 or COX11 or SCO1/2) 
need to be further examined. Thereby, the existence of the bioactive copper 
pool (Cobine et al., 2004) within the mt matrix that is used at least in part to 
metallate both COX and SOD1 should be considered (Cobine et al., 2006a). 
So far, it is not clear how copper ions enter the matrix and can be eventually 
recruited later to the mt IMS. Six additional soluble mt IMS proteins with 
highly conserved twin Cx9C motifs that are crucial to COX assembly have been 
identified (Horn and Barrientos, 2008; Longen et al., 2009). One candidate of 
special interest is Cmc1, since ablation of Cmc1 in yeast shifts the relative 
proportion of catalytically active COX and mt IMS-localized SOD1 (Horn et al., 
2008). Recent data suggest that copper is bound by a small non-
proteinaceous ligand, which passively diffuses across the OMM into the 
mt IMS. Copper is then chaperoned by Cmc1 or other, yet unidentified 
metallochaperones to Cox17, which uses distinct interfaces to transfer copper 
to Sco1/Sco2 for maturation of the CuA site of Cox2 and to Cox11 for 
maturation of the CuB site of Cox1 (Leary, 2010). 
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5 APPENDIX 
 
 
HeLa cells were transfected with COX17 siRNA 2 or negative control siRNA for the 
indicated times. Effect of COX17 knockdown on the proportions of cells in each cell 
cycle phase was determined with PI. A total of 20,000 cells were counted for each 
sample. 
 
Appendix, Figure 5.1. Cell cycle analysis by flow cytometry.
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HeLa cells were transfected with COX17 siRNA 2 or negative control siRNA for the 
indicated times. Cells were detached with trypsin and stained with CytoGLO™ Annexin 
V-FITC Apoptosis Detection Kit. A total of 20,000 cells were counted for each sample.  
 
2D-DIGE analysis of COX17 knockdown cells 
The preparation of mitochondria was carried out according to materials and 
methods, chapter 2.2.6.1 and to standard Applied Biomics protocol. Briefly, 
500 µg mitochondria of negative control siRNA and COX17 siRNA 2 
transfected cells 72 h post transfection were isolated, resuspended in 75 µl CL 
1 buffer (250 mM sucrose, 30 mM MOPS, pH 7.2) and flash-frozen in ethanol-
dry ice bath. The samples were shipped on dry ice to Applied Biomics. 
Samples were labeled with either Cy3 or Cy5 and simultaneously separated 
on a single 2-D gel, using isoelectric focusing (IEF) in the first dimension (pH 
gradient 3–10) and SDS-PAGE (10.5 % acrylamide) in the second dimension. 
After electrophoresis, the gel was scanned using Typhoon scanner to obtain a 
comparative analysis and accurate measurement of differential protein 
expression. Proteins of interest were automatically picked out from the 2D gel 
with Ettan Spot Picker and transferred for protein identification. The protein 
spots were then subjected to in gel digestion to enable identification by 
MALDI-TOF/TOF Mass Spectrometer. 
 
Appendix, Figure 5.2. Identification of apoptotic cells by flow cytometry. 
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Mt were isolated 72 h post transfection and were analyzed by 2D-DIGE (Applied Biomics). (a) Thirteen proteins changed significantly when 
2D-gel of control cells (negative siRNA transfected cells) was compared to 2D-gel of COX17 siRNA transfected cells (overlay gel images). (b) 
DeCyder Analysis and 3-D image of the spots of interest. (c) Increase or decrease of each spot, spots with indicated ratios were analyzed by 
MALDI/TOF. 
Appendix, Figure 5.3. 2D-DIGE analysis of COX17 knockdown cells.
(c) (b) 
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Spot 
number 
Top Ranked Protein Name 
(Species) 
Accession 
No. 
Protein 
MW 
Protein 
PI 
Protein 
Score 
Protein Score 
C.I.% 
2 
Chain A, crystal structure of the extracellular segment 
of integrin alpha/beta 3 
gi|16975253 105707.8 5.2 70 97.7 
3 Non-muscle myosin heavy chain (NMHC) gi|189036 144995.8 5.2 91 100.0 
5 Catenin, alpha 1 [Homo sapiens] gi|55770844 100008.5 6.0 72 98.5 
25 Heat shock protein 60 [Homo sapiens] gi|77702086 61174.4 5.7 295 100.0 
27 Vimentin gi|340219 53681.1 5.0 222 100.0 
28 Keratin 17 [Homo sapiens] gi|4557701 48076.0 5.0 337 100.0 
36 Cytokeratin 18 (424 AA) [Homo sapiens] gi|30311 47305.2 5.3 363 100.0 
43 
Chain A, crystal structure of H3 alpha-hydroxysteroid 
dehydrogenase type 3 mutant Y24a  
gi|150261301 36373.9 7.6 137 100.0 
44 Annexin A2 isoform 1 [Homo sapiens] gi|50845388 40385.7 8.5 291 100.0 
48 
Rho GDP dissociation inhibitor (GDI) alpha [Homo 
sapiens] 
gi|4757768 23192.7 5.0 265 100.0 
53 KRT17 protein [Homo sapiens] gi|47939651 40292.4 4.9 67 95.8 
55 
NADH dehydrogenase (ubiquinone) 1 beta 
subcomplex, 9, 22kDa [Homo sapiens] 
gi|6274550 21816.8 8.6 214 100.0 
61 
Chain A, secypa complexed with hagpia (pseudo-
symmetric monomer) 
gi|2981743 17789.7 7.8 115 100.0 
 
Appendix, Table 1. 2D-DIGE and mass spectrometry analysis of mitochondria of COX17 knockdown cells 72 h post 
transfection. 
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Tetracycline inducible shRNA expression 
Two different siRNA target sequences were identified by an algorithm that 
optimizes the Pol III promoter-based prediction of shRNA sequences, that 
efficiently degrade specific target transcripts via shRNA, offered by a design 
tool from Prof. Dr. K. Strebhardt (www.molgyn.kgu.de) (Kappel et al., 2007). 
The output provided a sequence of 70 nt with a 5´ BamHI site, a sequence of 
19 nt representing the sense strand of the shRNA, a sequence of 9 nt 
representing the loop of the hairpin structure for the processing of shRNAs 
that would generate a high frequency of siRNA, a region of 19 nt representing 
the antisense strand, a termination signal for Pol III consisting of five 
consecutive thymidine residues, and a 3´ HindIII site (Appendix, Figure 5.4 
(c)). psiRNA-hH1neo G2 vector was used as a backbone for the following 
three-step cloning procedure: (i) excision of the wt H1 promoter, (ii) insertion 
of the wt H1 promoter flanked by the appropriate restriction sites for the 
subsequent insertion of inducible promoter variants and (iii) replacement of 
the wt H1 promoter by inducible promoter variants (Appendix, Figure 5.4 
(a) + (b)). Following synthesis and annealing of the DNA oligonucleotides for 
COX17 shRNA expression, the molecules are ligated into the expression 
plasmid downstream of the inducible H1 promoter derivatives.  
For the generation of stable cells harboring the inducible RNAi cassette,          
T-REx™-HeLa cells* (Invitrogen) were transfected with 1 µg recombinant 
plasmid DNA (Kappel et al., 2007). The cells were cultivated in selection 
medium (1.5 mg/ml neomycin) for 20 days. After selection of single clones, 
cells were cultivated in the absence or presence of dox (1, 5 and 10 µg/ml). 
The cultivation of a couple of clones with 10 µg/ml of dox was not successful 
indicating that permanent loss of Cox17 may be lethal and would be in 
accordance with the reduced growth of the transiently silenced cells. The 
majority of clones showed a reduced growth after incubation with dox. The 
impact of the inducible COX17 shRNA expression was monitored on RNA and 
protein level. Initial results showed no reproducible and at the same time only 
marginal differences between the Tet-off and Tet-on state after induction with 
10 µg/ml dox (data not shown). Further experiments have to be performed to 
confirm that silencing of COX17 is based on activation of tetracycline inducible 
shRNA expression. 
                                                 
* T-REx-HeLa cells stably express the tetracycline repressor protein  
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(a) Map of the expression vector pwtH1. The vector psiRNA-hH1neo G2 was used as backbone and contains a wt H1 promoter (red) for 
expression of shRNA, a prokaryotic resistance gene against kanamycin (green) and a eukaryotic resistance gene against neomycin/Geneticin 
(G418) (also green). (b) The wt H1 promoter was replaced with Tet-inducible variants using the SpeI and BamHI restriction sites. The three 
sequence elements, which contribute to full promoter activity, are located adjacent to the transcription start site (+1): distal sequence element 
(DSE, magenta), proximal sequence element (PSE, blue) and TATA-box (TATA, orange). In the Tet - inducible variants of the H1 promoter the 
TetO sequence (TetO, dark green) is inserted upstream or/and downstream of the TATA-box. (c) For the expression of COX17 shRNAs the 
corresponding DNA fragment contains a 19 nt sense strand, a 9 nt loop and a 19 nt antisense strand. The expression is blocked by a 
termination signal containing five thymidine residues (TERM, red). This fragment is inserted into BamHI (5´) and HindIII (3´) sites of the 
expression vectors containing the wt H1 promoter or its Tet-inducible variants (taken in part from Kappel et al. (2007)).  
Appendix, Figure 5.4. Silencing of mammalian genes by tetracycline inducible shRNA expression.
(c) 
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6 PHD PUBLICATION RECORD 
Work, that was done during the time period of this thesis appeared in the 
following publication and were presented at the following conferences: 
 
Publication 
Oswald, C., Krause-Buchholz, U., Rödel, G., (2009). Knockdown of human 
COX17 affects assembly and supramolecular organization of cytochrome c 
oxidase. J Mol Biol. 389, 470–479 
 
Posters 
Krause-Buchholz, U., Löschner, C., Rödel, G., (2007). Essential role of 
cytochrome c oxidase in the development and maintenance of neuronal cells. 
CRTD Summer Conference on Regenerative Medicine, Dresden 
 
Oswald, C., Schulz, C., Krause-Buchholz, U., Rödel, G., (2008). Effects of 
silencing of the human assembly factors COX17 and SURF1 on cytochrome c 
oxidase. 
2nd CRTD Summer Conference on Regenerative Medicine, Dresden 
 
Oswald, C., Schulz, C., Krause-Buchholz, U., Rödel, G., (2008). Silencing of 
the human mitochondrial assembly factors COX17 and SURF1.  
5th International PhD Student Symposium, Göttingen 
 
Oswald, C., Krause-Buchholz, U., Rödel, G., (2009). Knockdown of human 
COX17 affects assembly and supramolecular organization of cytochrome c 
oxidase. 
Annual Conference of the German Genetics Society (GfG), Cologne 
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